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ABSTRACT 
NURSES’ USE OF HAZARDOUS DRUG SAFE HANDLING PRECAUTIONS 
by 
MARTHA POLOVICH 
Problem: Nurses are potentially exposed to hazardous drugs (HDs) in their practice. HD 
exposure is associated with adverse outcomes (reproductive problems, learning 
disabilities in offspring of nurses exposed during pregnancy, and cancer occurrence). 
Safe handling precautions (safety equipment and personal protective equipment, [PPE]) 
minimize exposure to HDs and decrease the potential for adverse outcomes. Despite 
existing OSHA recommendations, adherence to precautions is below recommendations. 
The purpose of this study was to examine relationships among factors affecting nurses’ 
use of HD safe handling precautions, to identify factors that promote or interfere with HD 
precaution use, and to determine nurse managers’ perspectives on use of safe handling 
precautions. This study used a conceptual model which proposes that both individual and 
organizational factors influence precaution use. 
Methods: A cross-sectional, correlational design was used. Nurses (N = 165; 46% 
response rate) from oncology centers across the US who reported handling chemotherapy 
completed a mailed survey. Instruments measured HD precaution use, knowledge, self 
efficacy, barriers, perceived risk, conflict of interest, interpersonal influences and 
workplace safety climate. Hierarchical regression was used. Twenty managers of nurses 
handling chemotherapy were interviewed.
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Results: Nurses were experienced in oncology (M = 15.8 ± 7.6) yrs, well-educated 
(62.5% ≥BSN), certified in oncology nursing (85%), worked in outpatient settings (69%), 
and on average treated 6.8 ± 5.2 patients per day. Chemotherapy exposure knowledge 
was high (M = 10.9, ± 1, 0-12 scale); as was self efficacy for using PPE (M = 20.8 ± 3, 7-
24 scale), and perceived risk (M = 3.14 ± .6, 0-4 scale). Total precaution use during HD 
administration and disposal was low (M = 1.9, SD = 1.1, 0= never to 5 = 100%). Nurse 
characteristics did not predict HD precaution use. In the final model (R2 = .29, F (2, 155) 
= 24.6, p < .000), fewer patients per day, fewer barriers and better workplace safety 
climate were independent predictors of higher precaution use.  
Conclusions: Results emphasize the importance of organizational influence on nurses’ 
HD safe handling precaution use and suggest fostering a positive workplace safety 
climate and reducing barriers as interventions. 
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CHAPTER I 
INTRODUCTION 
Over five and one half million healthcare workers (HCWs) are potentially 
exposed to hazardous drugs (HDs) in the workplace. While most drugs defined as 
hazardous are cytotoxic agents used in the treatment of cancer, many drugs used for other 
indications and in other patient populations are equally unsafe. The Occupational Safety 
and Health Administration [OSHA] acknowledged this occupational risk and issued 
recommendations for the safe handling of HDs more than twenty years ago (OSHA, 
1986). According to the National Institute for Occupational Safety and Health [NIOSH] 
(2004), there is documented evidence of contamination of the work environment with 
HDs, which increases the potential for exposure by nurses, pharmacists and other 
healthcare workers when these agents are handled inappropriately. 
Occupational exposure to HDs has been associated with acute symptoms such as 
hair loss, abdominal pain, nasal sores, contact dermatitis, allergic reactions, skin injury, 
and eye injury (Harrison, 2001). Adverse reproductive outcomes have been identified in 
many studies of nurses and pharmacists working with HDs, including fetal loss, 
miscarriage, or spontaneous abortions (Selevan, Lindbohm, Hornung, & Hemminki, 
1985; Stucker et al., 1990; Valanis, Vollmer, & Steele, 1999); fetal abnormalities; 
(Hemminki, Kyyronen, & Lindbohm, 1985); infertility (Fransman et al., 2007; Martin, 
2005; Valanis, Vollmer, Labuhn, & Glass, 1997); preterm births and learning disabilities 
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in offspring (Martin, 2005). Furthermore, consistent with the inherent carcinogenic 
potential of many HDs, there is an increase in the risk of cancer among occupationally 
exposed individuals (Hansen & Olsen, 1994; Martin, 2003; Skov et al., 1992). 
The best way to protect workers from a hazardous exposure is by elimination or 
substitution of the hazard, but this is not feasible with drug therapy. Next on the hierarchy 
of controls (U.S. Department of Labor, 1998) is the use of engineering controls to isolate 
or contain the hazard to prevent worker exposure. Education and training of those 
responsible for HD handling are examples of administrative controls, the next level of 
protection. The last level of protection is personal protective equipment (PPE) which is 
barrier protection between the worker and HDs, and is effective only when the worker 
uses PPE. 
Safe handling precautions include the use of safety equipment, work practices and 
PPE. All precautions, when used consistently, can reduce occupational exposure to HDs 
(NIOSH, 2004). Given the potentially serious consequences of HD exposure, one would 
expect that the use of safe handling precautions is high; however, safe handling 
precautions have neither been universally implemented by all nurses nor in all settings. 
Several studies on PPE use have been published since 1986, and all reported glove and 
gown use that was lower than current recommendations (Mahon et al., 1994; Martin & 
Larson, 2003; Nieweg, deBoer, Dubbleman et al., 1994; Stajicj, Barnett, Turner, & 
Henderson, 1986; Valanis, McNeil, & Driscoll, 1991; Valanis & Shortridge, 1987; 
Valanis, Vollmer, Labuhn, Glass, & Corelle, 1992). 
While many researchers have measured how often nurses use HD safe handling 
precautions, few studies have measured the impact of specific factors on nurses’ use of 
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HD safe handling precautions. Understanding factors that promote or interfere with HD 
safe handling precautions may help to develop targeted interventions to increase their 
use. 
Several factors are thought to influence the adoption of protective behaviors. 
These are knowledge about the hazard (Gershon et al., 1995; McGovern, Gershon, 
Rhame, & Anderson, 2000), perceived risk of harm (Levin, 1999; Martin, 2006), beliefs 
about personal susceptibility to harm (Brewer et al., 2007) perceived benefits of action 
(Lusk, Ronis, & Hogan, 1997) interpersonal influences (Hong, Lusk, & Ronis, 2005; 
Lusk et al., 1997) and personal and organizational factors (Gershon et al., 1999; Gershon 
et al., 1995). While these factors have been explored for other types of occupational 
health-protective behaviors, such as use of Universal Precautions (UP) (Gershon et al., 
2000; Gershon et al., 1999; Gershon et al., 1995), hearing protection devices (HPDs) 
(Hong et al., 2005; McCullagh, Lusk, & Ronis, 2002; Ronis, Hong, & Lusk, 2006) and 
eye protection (Lipscomb, 2000) few studies have explored factors that influence nurses’ 
use of precautions for HD handling. 
Purpose and Significance 
Exposure to hazardous chemicals in the workplace is a significant occupational 
problem for nurses. Nurses and other HCWs are subject to HD exposure during routine 
activities related to patient care. Exposure is associated with a risk of adverse health 
outcomes. Use of safety precautions can reduce nurses’ HD occupational exposure 
(NIOSH, 2004). 
Despite the availability of safety guidelines for more than twenty years (OSHA, 
1986), use of protective equipment is less than ideal. Recent studies found that 25-40% of 
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nurses used improper gloves for chemotherapy handling and up to 69% of nurses failed to 
wear gowns (Martin & Larson, 2003; Polovich & Martin, 2008, February). The reasons 
that some nurses do not incorporate safety precautions into their practice are not fully 
understood. Knowledge about nurses’ decision to use safety precautions is necessary to 
provide guidance in designing interventions to increase their use and reduce hazardous 
exposures.  
The purpose of this study was to examine factors that are thought to influence the 
use of HD safe handling precautions. Identifying factors that predict the use of HD safe 
handling precautions is essential to the consistent implementation of these measures. This 
study provides valuable information to promote safety for nurses doing hazardous work. 
Reducing exposure to HDs will decrease the potential for adverse health outcomes and 
improve the safety and quality of life for nurses.  
The following aims, hypotheses and research questions were proposed: 
Specific Aim 1: Determine the influence of individual and organizational factors 
on nurses’ use of safe handling precautions for nurses exposed to HD in their practice.  
Hypothesis 1a: Nurses’ individual characteristics (higher knowledge, higher 
perceived risk of harm from HD exposure, higher self-efficacy for using PPE and fewer 
perceived barriers to using PPE) will be associated with an increased use of HD safe 
handling precautions. 
Hypothesis 1b: Organizational factors (better workplace safety climate and 
interpersonal influences) will be associated with increased use of safe handling 
precautions. 
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Hypothesis 1c: Nurses’ individual characteristics (higher knowledge, higher 
perceived risk of harm from HD exposure, higher self-efficacy for using PPE, fewer 
barriers to using PPE) and organizational factors (better workplace safety climate and 
interpersonal influences) will each account for significant variance in use of safe handling 
precautions.  
Research Question 1d: Does nurses’ perceived conflict of interest (need to protect 
self vs. need to provide medical care) moderate the relationship between self-efficacy for 
using PPE and use of safe handling precautions? 
The secondary aim of the study was to determine nurse managers’ perspectives on 
use of safe handling precautions in the workplace. The research questions were: 
Research Question 2a: What are nurse managers’ perceptions of the 
organizational safety climate for safe handling precautions? 
Research Question 2b: For nurses they supervise, what are nurse managers’ 
perceptions of nurses’ use of safe handling precautions? 
Theoretical Framework 
The use of safe handling precautions, particularly PPE, is conceptualized as self-
protective behavior. DeJoy (1996) describes several theoretical models that are applicable 
to workplace self-protective behavior. Some are expectancy-value models, such as the 
Health Belief Model (HBM) (Janz & Becker, 1984) and the Theory of Planned Behavior 
(TPB) (Ajzen, 1991) which are based on threat-related beliefs or perceptions about a 
behavior. They incorporate concepts related to an individual’s attitudes, beliefs, and 
expectations about health threats, and are often referred to as cognitive models. 
Contextual or environmental models take into account the interaction between the person 
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and the situation or environment that influences behavior. Some examples are the 
PRECEDE model (Dejoy, 1986) and the Health Promotion Model (HPM) (Pender, 
Murdaugh, & Parsons, 2006). Because these models include individual and 
environmental factors, they are referred to as integrative models (Peterson & Bredow, 
2003). Another category includes behavior models that focus on the process, and describe 
behavior change in terms of stages, such as the Transtheoretical Model (Prochaska, 
DiClemente, & Norcross, 1992) and the Precaution Adoption Process (Weinstein, 1988). 
These models propose that factors relevant to adopting protective behaviors vary 
depending on the readiness of individuals to alter their behavior. All of the above-
mentioned perspectives have been used to explain self-protective behavior; however, the 
process models are not well-studied in HCWs and there is less support for their 
usefulness in those settings. 
The Factors Predicting Use of HD Safe Handling Precautions (PHDP) model was 
used for this study (Figure 1). It is a model adapted from the Predictors of Use of Hearing 
Protection Model (PUHPM) (Lusk et al., 1997) which was derived from the HPM 
(Pender et al., 2006). The HPM is based on three theories: The Theory of Reasoned 
Action (Ajzen & Fishbein, 1980) the Theory of Planned Behavior (Ajzen, 1991) and 
Social Cognitive Theory (Bandura, 1999). 
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The variables in the PHDP are knowledge about HD exposure, perceived risk of 
harm from HD exposure, self-efficacy for using PPE, barriers to using PPE, 
organizational safety climate and workplace interpersonal influences, and perceived 
conflict of interest between protecting self and providing patient care. The theoretical 
predictor variables and their relationships are discussed below.  
 Safe Handling Precautions. The use of HD safe handling precautions is the 
behavior of interest. It is a specific type of self-protective behavior, and includes the use 
of safety equipment, work practices and PPE. 
Knowledge about HD exposure is defined as information about both the risks of 
HD exposure and the effectiveness of precautions in preventing exposure. Knowledge is 
necessary for an individual to begin thinking about a health hazard. The PUHPM includes 
“benefits of use,” also called “value of use,” which is characterized as an attitude in the 
model, but is dependent upon knowledge. For example, an item in the Use of Hearing 
Protection Questionnaire (Lusk, 2006) “wearing hearing protection protects me against 
hearing loss from noise exposure” reflects knowledge related to HPD use. 
Figure 1. Factors Predicting Use of HD Safe Handling Precautions 
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Perceived risk is a cognitive process where individuals consider the seriousness of 
a threat, personal susceptibility, personal severity, and short and long-term threat related 
to a situation. Individuals are not likely to engage in risk-reducing behaviors until they 
recognize personal susceptibility (Brewer et al., 2007). The Health Belief Model (Janz & 
Becker, 1984) the Precaution Adoption Process (Weinstein & Sandman, 1992) and an 
extended Theory of Planned Behavior (Levin, 1999) all include perceived risk as a 
predictor of behavior. The HPM does not include the concept of risk as a motivator, but 
was originally designed to explain health-promoting behaviors. Use of PPE is a health-
protective behavior, rather than health-promoting. Motivation for protective behavior 
must necessarily consider the concept of risk. It is proposed that knowledge of HD 
exposure is related to perceived risk of harm from HD exposure and that perceived risk is 
positively related to the use of HD safe handling precautions. 
Self-efficacy is the judgment of a person’s ability to carry out a particular 
behavior. According to the PUHPM model, self efficacy has a direct effect on HPD use 
(Lusk et al., 1997). Self-efficacy is related to knowledge. Additionally, higher self 
efficacy decreases the perception of barriers to performing a health-protective behavior 
(Pender et al., 2006; Ronis et al., 2006). In the PHDP model, self-efficacy refers 
specifically to use of PPE for HD protection. 
Barriers are impediments to engaging in a behavior that a person decides to 
adopt. These barriers may include “unavailability, inconvenience, expense, difficulty, or 
time-consuming nature of a particular action” (Pender et al., 2006, p. 53). Perceived 
barriers are expected to be negatively related to self-efficacy as well as the use of safe 
handling precautions. In the PHDP model, barriers are those that interfere with PPE use. 
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Organizational influence refers to perceptions by an employee about the 
commitment of the employer to promote a safe work environment. A positive 
relationship was found between organizational commitment to safety and compliance 
with UP (Gershon et al., 2000; Gershon et al., 1999; Gershon et al., 1995). Organizational 
influence is proposed to affect HD safe handling precautions in several ways: a direct 
effect on use of precautions; an indirect effect by decreasing perceived barriers; and an 
indirect effect by increasing social modeling of precaution use. 
Interpersonal influence in the workplace is part of the organizational climate, and 
refers to the impact of important others’ attitude toward and encouragement of the use of 
protective equipment. This includes social modeling, which is a significant predictor of 
HPD use (Hong et al., 2005; Lusk et al., 1997). The findings in HPD studies indicate that 
workers are more likely to use protective equipment if their co-workers do. This had not 
been previously studied with HD safe handling precautions and the same relationship was 
anticipated, although not supported by this study. 
Perceived conflict of interest is defined by Gershon and others as a conflict 
“between workers’ need to protect themselves and their need to provide medical care to 
patients” (1995, p. 225). It is a specific type of “immediate competing demand” in the 
revised HPM (2006) but the variable is not well studied. In one report, HCWs with low 
levels of conflict of interest were more than twice as likely to comply with UP as those 
with high levels (Gershon et al., 1995). Higher perceived conflict of interest is expected 
to interfere with HD precaution use. 
The proposed model of factors influencing the use of HD safe handling 
precautions is adapted from a model that has consistently predicted HPD use, a type of 
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protective behavior. Perceived risk is included because it is an important variable in other 
health behavior models and the fact that it predicts other health-protective behaviors. 
Perceived conflict of interest is included because it affects UP use, which is similar to HD 
precaution use. Because of the suggested relationships between organizational influences 
and the other predictor variables, this variable is proposed to strongly predict the use of 
HD safe handling precautions. 
The HPM emphasizes the role of behavior-specific factors on the outcome of 
interest (Pender et al., 2006). It is essential to identify factors that are salient to each 
particular type of self-protective behavior. PPE use by HCWs is a specific self-protective 
behavior that is undertaken by an individual for the purpose of protection against a future 
adverse health effect, and it requires ongoing adherence over a long period of time. The 
PHDP model represents an adaptation of the HPM and the PUHPM to include those 
factors with high relevance to this self-protective behavior. 
The uniqueness of the healthcare environment suggests the need for specific 
predictors. Nurses work most often as employees rather than as independent practitioners 
in hospitals, clinics, or physician office practices; therefore, organizational influence is 
expected to affect PPE use. The PHDP proposes that organizational commitment to 
safety has a direct effect on use of precautions. This relationship is supported in several 
studies of UP use (Gershon et al., 2000; Gershon et al., 1995; Stone, Du, & Gershon, 
2007; Stone & Gershon, 2006). 
Perceived conflict of interest is another factor that is unique to patient care 
situations. This concept is not a part of the PUHPM because it is not relevant to HPD use. 
The PHDP incorporates perceived conflict of interest because it is particularly relevant to 
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HCWs’ use of self-protective behavior (Gershon et al., 1995; Lymer, Richt, & Isaksson, 
2004). 
To summarize the proposed relationships of the PHDP model, depicted in Figure 
1, knowledge of the hazard is related to perceived risk and self-efficacy. Self efficacy is 
expected to decrease perceived barriers. Organizational influences are expected to 
decrease perceived barriers. Perceived risk, self-efficacy, perceived barriers, 
organizational influences and interpersonal influences are expected to influence use of 
safe handling precautions. Finally, perceived conflict of interest is proposed to influence 
the use of safe handling precautions. 
Assumptions 
The following are assumptions inherent in the PHDP: 
• Individuals value health and therefore seek to protect their health 
• Individuals strive to regulate their own behavior 
• Individuals are complex beings who interact with their environment 
• Organizations differ in their values related to health and safety 
• Clinical situations are unique situations that influence HCWs’ priorities 
The most important assumption related to the PHDP is that self-protective 
behavior is not a function of individual motivation alone. The workplace environment 
influences how and when workers engage in self-protective behavior. Healthcare 
organizations promote patient health and safety, but worker safety may vary in priority 
from one setting to another. In addition, HCWs may feel as though they must choose 
between their own safety and the safety of patients in care situations (Gershon et al., 
1995; Lymer et al., 2004). The findings from one qualitative study on UP precautions 
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prompted the authors to comment, “On a conceptual level, this means that non-
compliance [with precautions] must be conceived as being a natural tendency in clinical 
work” (Lymer et al., 2004, p. 548).  
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CHAPTER II 
LITERATURE REVIEW 
This chapter provides an overview of the adverse effects of occupational exposure 
to hazardous drugs; a summary of recommended HD safe handling precautions; and 
factors that are thought to influence the use of protective behaviors. 
Adverse Effects of Occupational Exposure to Hazardous Drugs 
Evidence of the adverse effects of HD exposure has been available since the 
1970’s. Several chemotherapy agents were linked to secondary leukemia and other 
cancers in patients who received antineoplastic agents for primary, un-related 
malignancies (Harris, 1976; Penn, 1976; Rosner, 1976). This information was soon 
followed by concern that the risk might extend to healthcare workers exposed to the 
drugs in the course of their work (Donner, 1978; Ng & Jaffe, 1970). Lancet published the 
first convincing evidence of health care worker exposure in a letter to the editor in 1979 
(Falck et al.). In a small but controlled study, mutagenic activity was found in the urine of 
patients who received chemotherapy and nurses who administered the chemotherapy. The 
investigators had intended the nurses to be the control group, but instead found evidence 
of their exposure. In several recently published studies, hazardous drugs have been 
measured in the urine of nurses, pharmacists and pharmacy technicians (Pethran et 
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al., 2003; Sessink & Bos, 1999; Wick, Slawson, Jorgenson, & Tyler, 2003), indicating 
that there has been little reduction in exposure in over twenty-five years. 
Acute symptoms have been reported in nurses and pharmacists who were 
occupationally exposed to HDs. These include hair loss, abdominal pain, nasal sores, 
contact dermatitis, allergic reactions, skin injury, and eye injury (Harrison, 2001; Valanis, 
Vollmer, Labuhn, & Glass, 1993a, 1993b). Adverse reproductive outcomes have been 
identified in nurses and pharmacists working with HDs, including miscarriage (OR = 
1.01, p = .03) (Martin, 2003), spontaneous abortions (OR = 1.5-2.3) (Selevan et al., 1985; 
Stucker et al., 1990; Valanis et al., 1999); fetal abnormalities (OR = 4.7, p = .02) 
(Hemminki, et al., 1985); infertility (OR = 1.42-1.5) (Martin, 2003; Valanis et al., 1997) 
longer time to conception (OR = .8) (Fransman et al., 2007); preterm labor (OR = 2.98, 
p< .01), preterm births (OR = 5.56, p < .01) and learning disabilities (OR = 2.56, p < .01) 
in offspring of nurses exposed during pregnancy (Martin, 2005). Consistent with the 
inherent carcinogenic potential of twenty-three chemotherapy agents (International 
Agency for Research on Cancer, 2007), there is an increased relative risk (RR) of cancer 
among occupationally exposed pharmacy technicians (RR = 1.1-3.6) (Hansen & Olsen, 
1994) and nurses (RR = 10.65) (Skov et al., 1992). More recently, Martin (2003) found 
that exposed nurses were significantly more likely to report a cancer diagnosis than 
unexposed nurses (OR = 3.27, p = .03). In that study, the nurses’ age at initial cancer 
diagnosis was younger than that reported in the Surveillance, Epidemiology, and End 
Results [SEER] Data (National Cancer Institute, 1999).  
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Safe Handling Precautions for HD Handling 
Since exposure to HDs is associated with adverse outcomes, safe handling 
precautions are recommended to reduce or eliminate exposure for health care workers. 
The first guidelines were published by the American Society of Hospital Pharmacists 
(ASHP, 1985), and these influenced the Occupational Safety and Health Administration 
document (OSHA, 1986). Professional organizations such as the American Medical 
Association [AMA] (1985) and the Oncology Nursing Society [ONS] (Polovich, 
Whitford, & Olsen, 2009) and NIOSH, a governmental agency (2004) have published 
similar guidelines. The recommended methods for reducing HD exposure include 1) 
biological safety cabinets (BSCs) to protect against inhalation exposure during drug 
preparation; 2) two pairs of disposable gloves that are powder free and have been tested 
for use with HDs; 3) a disposable gown made of chemical-protective fabric with long 
sleeves, cuffs and back closure; 4) A NIOSH-approved respirator to protect against 
aerosols; 5) eye and face shield that provides splash protection; 6) administrative controls 
and 7) careful work practices to reduce opportunities for exposure. All precautions, when 
used consistently, can reduce occupational exposure to HDs (NIOSH, 2004; OSHA, 
1995).  
Given the risks of exposure, use of safe handling precautions should be high; 
however, safe handling recommendations have not been universally implemented. 
Several studies on PPE use for HD handling have been published since the 1986 OSHA 
guidelines (Mahon et al., 1994; Martin & Larson, 2003; Nieweg et al., 1994; Stajicj et al., 
1986; Valanis et al., 1991; Valanis & Shortridge, 1987; Valanis et al., 1992). These 
studies reported variation in PPE use by nurses based on the type of HD handling 
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activity. Glove use ranged from 49-99% for drug preparation and 15-94% for drug 
administration; while gown use ranged from 3-63% for drug preparation and 3-31% for 
drug administration. Not all studies reported PPE use for handling patient’s HD-
contaminated excretions and for disposal of chemotherapy, but when reported it ranged 
from 58-96% for gloves and 4-23% for gowns (Martin & Larson, 2003; Polovich & 
Martin, 2008, February; Valanis et al., 1991).  
The PPE studies published before 1990 demonstrated the lowest glove use (Stajicj 
et al., 1986; Valanis & Shortridge, 1987). All of the PPE studies published after 1990 
demonstrated higher glove use for HD preparation and administration (Mahon et al., 
1994; Martin & Larson, 2003; Nieweg et al., 1994; Valanis et al., 1991; Valanis et al., 
1992), but it still fell short of recommendations. Recent studies continue to report less 
frequent PPE use for handling HD-contaminated excretions and drug disposal. In 
addition, the newer guidelines (ASHP, 2006; NIOSH, 2004; Polovich et al., 2009) 
recommend double gloves for all HD handling activities. In one recent study, adoption of 
this precaution was only 11-18% (Polovich & Martin, 2008, February). 
Many studies did not report the type of gloves used for HD handling. Two studies, 
however (Martin & Larson, 2003; Polovich & Martin, 2008, February) found that 25-
40% of nurses used gloves not designated for use with chemotherapy. They found that 
nurses working in private physician office practices where chemotherapy is prepared and 
administered were less likely to have access to appropriate PPE. Because permeation 
studies indicate that many medical gloves provide limited protection from HDs (Connor, 
1999; Gross & Groce, 1998; Klein, Lambov, Samev, & Carstens, 2003; Singleton & 
Connor, 1999), not all gloves are appropriate for HD handling. This is particularly 
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important because hands are the most frequent site of dermal exposure to HDs 
(Fransman, Vermeulen, & Kromhout, 2004, 2005). 
Gowns are recommended for HD handling in all published guidelines. Most 
studies indicate that gowns are used more frequently for HD preparation than for HD 
administration, although overall gown use does not meet OSHA guidelines (Mahon et al., 
1994; Martin & Larson, 2003; Nieweg et al., 1994; Valanis et al., 1991; Valanis & 
Shortridge, 1987; Valanis et al., 1992). Additionally, some studies have reported that 
nurses wear gowns made of cloth and other materials that are not designated for HD 
handling (Mahon et al., 1994; Martin & Larson, 2003; Polovich & Martin, 2007, March; 
Valanis & Shortridge, 1987). Such gowns provide limited protection against chemical 
permeation (Connor, 1993; Harrison & Kloos, 1999) and should not be used for HD 
handling. In addition, Polovich & Martin (2008, February) found 58% of nurses reported 
reusing disposable gowns for HD preparation and 38% of nurses reused disposable 
gowns for HD administration. Reuse of disposable gowns may increase the chance of 
contaminating clothing. 
To date, there have been eight published studies on PPE use with chemotherapy 
(Mahon et al., 1994; Martin & Larson, 2003; Nieweg et al., 1994; Polovich & Martin, 
2008, February; Stajicj et al., 1986; Valanis et al., 1991; Valanis & Shortridge, 1987; 
Valanis et al., 1992) (See Table 1). All of the studies that measured use of HD safe 
handling precautions were descriptive, cross-sectional studies. One study used a 
comparative design in reporting nurses’ and pharmacists’ use of safe handling 
precautions before and after publication of OSHA guidelines (Valanis et al., 1992). Two 
studies examined relationships between the use of HD safe handling precautions and 
18 
 
nurse characteristics (such as years of experience) and work site characteristics (such as 
type of setting) (Martin & Larson, 2003; Polovich & Martin, 2008, February).  
Table 1 
Studies of Safe Handling Precautions 
 
Authors Sample Reported PPE Use 
Stajicj et al., 1986 33 registered nurses 
employed in oncologists’ 
private practices in 
Georgia 
Drug preparation: 
Gloves = 49%   Gowns = 3% 
Drug administration: 
Gloves = 15%   Gowns = 3% 
Valanis & 
Shortridge, 1987 
632 ONS members who 
mix and/or administer 
antineoplastic drugs. 
Drug preparation: 
Gloves = 76%   Gowns = 36% 
Drug Administration: 
Gloves = 50%   Gowns = 14% 
Valanis et al., 1991 125 staff from 14 facilities 
in Southwestern Ohio, 
including 7 physicians, 93 
nurses, 22 pharmacists & 
technicians, and 3 nurse 
aides/ housekeeping staff 
Drug preparation: 
Gloves =91%   Gowns = 41 % 
Drug administration: 
Gloves = 78%   Gowns = 12% 
Valanis, et al., 1992 1932 nurses and 153 
nurses aides from >200 
health care facilities 
currently handling HD’s 
Drug preparation: 
Gloves = 92%   Gowns = 63% 
Drug administration: 
Gloves = 82%   Gowns = 23% 
Handling excreta 
Gloves = 67%   Gowns = 4% 
 
(Table 1 Continues)
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(Table 1 Continued) 
Authors Sample Reported PPE Use 
Mahon et al., 1994 103 nurses, 83 of whom 
handle chemotherapy, from 
an ONS chapter in a large 
Midwestern city. 
Drug preparation: 
Gloves = 90%   Gowns = 44% 
Drug administration: 
Gloves = 94%   Gowns = 59% 
Patient care: 
Gloves = 94%   Gowns = 12% 
Nieweg et al., 1994 824 nurses from 11 Dutch 
hospitals 
Drug administration: 
Gloves = 91%   Gowns = 21% 
Mask = 18%      Goggles = 3% 
Martin & Larson, 
2003 
263 ONS members; nurses 
from outpatient settings 
Drug preparation: 
Gloves = 99% Gowns = 53% 
Drug administration: 
Gloves = 94% Gowns = 31% 
Handling excretions: 
Gloves = 96%   Gowns = 23% 
Polovich & Martin, 
2008 
330 nurses attending an 
ONS conference from 
various settings who 
handle chemotherapy 
Drug preparation: 
Gloves = 98%   Gowns = 91% 
Drug administration: 
Gloves = 99%   Gowns = 84% 
Drug disposal: 
Gloves = 99%   Gowns = 75% 
Handling excreta: 
Gloves = 99%   Gowns = 77% 
 
Each study evaluated PPE use by self-report measures. Instrument content 
validity was evaluated using experts in all studies except one (Nieweg et al., 1994) in 
which validity was not reported. Martin & Larson (2003) reported observing PPE use in 
20 
 
ten study participants, which matched their self-report for all but two items. Reliability 
was most often evaluated using test-retest procedures with kappa reported in the range of 
.64-1.0 (Martin & Larson, 2003; Valanis & Shortridge, 1987; Valanis et al., 1992).  
Three studies included participants who were members of ONS (Mahon et al., 
1994; Martin & Larson, 2003; Valanis & Shortridge, 1987) and one recruited participants 
from a national ONS conference (Polovich & Martin, 2008, February). It is estimated that 
only 50 % of practicing oncology nurses in the United States are ONS members (A. 
Stengel [ONS Membership Services], personal communication, December 3, 2007). 
Because of the educational resources of the organization, ONS members may be biased 
toward better handling practices. No studies have examined use of PPE by nurses who 
administer HDs for non-oncology indications such as rheumatoid arthritis, multiple 
sclerosis, or tubal ectopic pregnancy. Thus, samples in these studies are not likely 
representative of all nurses handling HDs. The current study sought to include nurses 
who are not members of ONS as well as members in order to obtain a sample that is more 
representative of nurses handling chemotherapy in the U.S. 
In summary, the use of PPE has improved over time. In the 20 years since the 
OSHA Guidelines, oncology nurses have incorporated the use of gloves for handling 
HDs into their practice. Some areas of concern remain, such as the fact that 
chemotherapy-designated gloves are not used in all settings; that double-gloves are used 
infrequently; that some nurses do not wear gloves for all HD handling activities; and that 
gown use continues to be low. Appropriate PPE may not always be available. 
Additionally, nothing is known about nurses’ adherence to HD safe handling precautions 
outside of oncology settings. 
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Requirements for Hazardous Drug Handling 
OSHA standards are part of the Code of Federal Regulations (CFR) and have the 
force of law. One example is the OSHA Bloodborne Pathogen Standard (U.S. 
Department of Labor-OSHA, 1991) which requires blood and body fluid precautions and 
use of safe needle devices in healthcare (OSHA, 2007). OSHA has the authority to cite 
and fine organizations that fail to provide appropriate safety equipment and precautions 
to its employees. In contrast, HD safe handling recommendations are guidelines rather 
than mandates from OSHA. This fact has led some organizations to consider the OSHA 
HD guidelines optional. 
Selected aspects of the OSHA HD guidelines are required by other standards. 
These applicable standards include the Hazard Communication Standard (29CFR 
1910.1200), which requires employers to inform employees of the risks of hazardous 
materials in their workplace and the methods of protecting themselves. The same 
standard requires Material Safety Data Sheets (MSDS) to be available for all chemical 
hazards (OSHA, 1994). Recent regulations regarding HD preparation (U.S. 
Pharmacopeial Convention, 2008) have elevated the OSHA recommendations to 
standards that are enforceable by the Food and Drug Administration (FDA).  
Employers’ responsibilities are outlined in the OSHA guidelines and the NIOSH 
recommendations. According to the recommendations, employers should have policies & 
procedures for safe handling; provide hazard communication training; provide a BSC for 
drug preparation; provide appropriate PPE for those handling HDs; have MSDS’s 
available for all HDs, and monitor potentially-exposed employees in a medical 
surveillance program.  
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In summary, regulations regarding employee safety when handling HDs are not 
consistent with the recommendations. While some components of workplace HD safety 
programs are regulated, others are not. Consequently, organizations vary in their 
interpretation of HD safety requirements, resulting in variable implementation of HD safe 
handling precautions.  
Factors Influencing Adoption of Protective Behaviors 
The use of safe handling precautions can be described as protective behavior. 
Little is known about the factors contributing to nurses’ decision to use safe handling 
precautions when handling HDs; however, use of protective equipment for protection 
against other occupational hazards such as blood and body fluids (Gershon et al., 1995) 
high noise (McCullagh et al., 2002), industrial chemicals (Geer, Curbow, Anna, Lees, & 
Buckley, 2006) and eye injury (Forst et al., 2006) has been examined. Worker protective 
behavior for other occupational hazards is thought to be influenced by personal factors 
(Gershon et al., 1999; Gershon, Sherman, et al., 2007; Hong et al., 2005; McGovern et 
al., 2000), knowledge about the hazard, (Geer et al., 2006; Gershon et al., 1995; 
Raymond, Hong, Lusk, & Ronis, 2006), perceived risk of harm, (Gershon et al., 1995; 
Levin, 1999; Martin, 2006), self-efficacy (Kerr, Lusk, & Ronis, 2002; Lusk, Kerr, Ronis, 
& Eakin, 1999; Lusk, Ronis, & Baer, 1995; Lusk et al., 1997; Lusk, Ronis, Kerr, & 
Atwood, 1994; Raymond et al., 2006; Ronis et al., 2006) barriers (Forst et al., 2006; 
Gershon et al., 1995; Kerr et al., 2002; Lusk et al., 1994; McCullagh et al., 2002) 
organizational influences (Gershon et al., 2000; Gershon et al., 1995; Stone et al., 2007; 
Stone & Gershon, 2006) interpersonal influences, [modeling and encouraging PPE use by 
co-workers] (Lusk et al., 1997; McCullagh et al., 2002; Raymond et al., 2006; Ronis et 
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al., 2006) and situational factors (Gershon et al., 1995; Hong et al., 2005; McCullagh et 
al., 2002). 
Personal Factors 
Individual characteristics may affect the adoption of protective behaviors. The 
effect of years of experience on precaution use reported in the literature is inconsistent. 
More years of experience was associated with higher UP use in healthcare workers 
(McGovern et al., 2000) and HPD use among White automotive manufacturing workers 
(Hong et al., 2005). In contrast, years of working in a plant negatively predicted HPD use 
among automotive manufacturing workers (Raymond et al., 2006) and construction 
workers (Lusk et al., 1997; Ronis et al., 2006). In two large descriptive studies of nurses 
handling HDs (Martin, 2006; Martin & Larson, 2003), nurses with fewer years of 
oncology experience were more likely to wear gowns when handling HDs and nurses 
with more years of experience generally had a lower perceived risk of harm from HD 
exposure. Since personal factors are not modifiable, this is not a primary variable of 
interest in this study. However, these data were collected for descriptive purposes and for 
their potential use as covariates. 
Knowledge of the Hazard 
People must be aware of the existence of a hazard in order to know that they 
should protect themselves from the hazard (Weinstein 1988; Weinstein, Lyon, Sandman, 
& Cuite, 1998; Weinstein & Sandman, 1992). In studies of dermal chemical exposure in 
industrial settings, workers’ lack of knowledge about characteristics of chemicals that 
affect skin absorption was associated with lower use of protective equipment (Geer et al., 
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2007; 2006). In healthcare settings, more knowledge about human immunodeficiency 
virus (HIV) transmission (Gershon et al., 1995; McGovern et al., 2000) and training in 
PPE use (Gershon et al., 1995; McGovern et al., 2000) have been associated with 
statistically significant better UP compliance.  
Regarding HD safe handling precautions, Ben Ami and colleagues found that 
lower use of precautions was related to lack of knowledge (Ben Ami, Shaham, Rabin, 
Melzer, & Ribak, 2001) and Harrison and colleagues found that education and training 
improved HD safe handling (Harrison, Godefroid, & Kavanaugh, 1996). 
In a study of nurses working in outpatient and office-based oncology settings, 
Martin and Larsen (2003) found that oncology certified nurses were less likely than those 
nurses who were not oncology certified to use gowns while disposing of chemotherapy 
and handling excreta contaminated with HDs. Since certification examinations measure 
knowledge, nurses with a higher level of knowledge would be expected to be more aware 
of the risks of HD exposure, and thus more likely to use PPE. No workplace 
characteristics were suggested to account for this unexpected finding, which warrants 
further exploration. 
Perceived Risk of Harm from HD Exposure 
Risk perceptions are important in situations where individuals make decisions to 
engage in a protective behavior (Brewer et al., 2007). Brewer asserts that there are three 
dimensions of perceived risk: perceived likelihood, perceived susceptibility and 
perceived severity, and that each is related to the threat of harm when no action is taken. 
In a meta-analysis, Brewer and colleagues examined thirty-four studies (N = 15,988) to 
test the hypotheses that higher perceived likelihood, perceived susceptibility and severity 
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are associated with adults obtaining vaccinations. All three dimensions of risk perception 
significantly predicted vaccination behavior, showing a consistent relationship between 
risk perception and the adoption of a specific protective behavior (Brewer et al., 2007).  
Only three descriptive studies have reported perceived risk related to PPE use for 
HD handling. In the first, a study of 632 nurses who mix and/or administer antineoplastic 
drugs, 25% reported they did not believe there is danger as one reason for not using PPE 
(Valanis & Shortridge, 1987). Valanis and others (1991) reported a lack of awareness of 
risk associated with HD handling among 9% of nurses and physicians. In the third study, 
Martin (2006) examined the relationship between the degree of perceived health risk 
associated with handling chemotherapy and the use of precautions by 500 randomly-
selected nurses working in outpatient oncology settings. Fifty percent of nurses indicated 
that the drugs were “minimally hazardous” and 5% described the drugs as “not 
hazardous.” Since these nurses worked in outpatient and office-based oncology practices 
primarily administering chemotherapy, there is no reason to suspect that these nurses 
handled drugs that were less hazardous than their colleagues. The degree of perceived 
risk of harm from HD exposure was lower among nurses with more years of oncology 
and chemotherapy experience. More importantly, the use of gowns was significantly 
lower among those nurses with lower perceived risk. Similar results were found in studies 
of compliance with UP in general (Gershon et al., 1995) and the use of gloves when 
potentially exposed to blood (Levin, 1999).  
Self Efficacy for use of Personal Protective Equipment 
Perceived self efficacy is “the judgment of personal capability to organize and 
carry out a particular course of action” (Pender et al., 2006, p. 53), and is an important 
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concept in several health behavior models. In the context of occupational health, this 
variable was found to predict HPD use (Kerr et al., 2002; Lusk et al., 1999; Lusk et al., 
1995; Lusk et al., 1997; Lusk et al., 1994; Raymond et al., 2006; Ronis et al., 2006). Self 
efficacy is not well studied in relation to blood and body fluid exposure. The effect of 
self-efficacy on UP compliance has been mixed, with one study finding a relationship 
(Sinclair, 1998) and two studies finding none (Mitchell, 1995; Patros, 2002), although the 
latter studies may have been under-powered because of small sample size. Self efficacy 
for PPE use was not significantly related to protective behavior for chemical exposure in 
industrial settings (Geer et al., 2007). This variable has not been studied in HD handling, 
but was included because of its relationship to some other health protective behaviors and 
conceptual links in the model. 
Barriers to Using Personal Protective Equipment 
Barriers interfere with workers’ use of protective behaviors. They may be 
practical (such as lack of available protective equipment), psychosocial (e.g. peer or 
patients’ attitudes) or situational (such as time constraints). Perceived barriers are 
negatively related to HPD use (Kerr et al., 2002; Lusk et al., 1994; McCullagh et al., 
2002), UP compliance (Gershon et al., 1995) and workers’ use of eye protection (Forst et 
al., 2006). The most commonly reported barriers to using PPE across occupational 
settings are time pressure or lack of time, peer acceptability, and negative outcome 
expectancy (Geer et al., 2006). 
A few studies have reported barriers to using HD safe handling precautions. Three 
studies reported reasons for not wearing PPE identified by nurses or pharmacists (Mahon 
et al., 1994; Valanis et al., 1991; Valanis & Shortridge, 1987). The findings were similar, 
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and included all of the following: lack of time, lack of availability of or accessibility to 
PPE, lack of awareness that non-use is potentially hazardous, not being convinced of the 
need for PPE, cost of protective equipment, discomfort associated with wearing PPE, and 
concern that PPE would upset patients. In a study of chemotherapy gown effectiveness, 
Harrison and Kloos (1999) asked participants to rate the subjective comfort of several 
gowns. Those gowns that provided the best protection were rated the least comfortable to 
wear. The heat-retaining quality of chemical protective gowns is a potential barrier to 
use. None of these studies measured the effect of barriers on use of precautions or the 
relative importance of certain barriers. Since all barriers cannot be eliminated, it is 
essential to gain a better understanding of those factors having the most impact.  
Organizational Culture and Safety Climate 
The aspects of organizations affecting protective behaviors have been variously 
referred to as “organizational culture,” “organizational climate” and “safety climate.” 
These terms are defined in the following section. 
Organizational culture refers to the underlying principles, norms, values, beliefs, 
and assumptions within an organization (Ostroff, 2001). Culture is a highly abstract 
construct that encompasses all aspects of work and the work setting. There are many 
cultures within healthcare organizations, such as ethical conduct and patient safety 
(DeJoy, Schaffer, Wilson, Vandenberg, & Butts, 2004; Gershon, Stone et al., 2007). 
Employee safety is the specific culture of interest for this study.   
Organizational climate is how culture is experienced by workers, and refers to 
employees’ collective perceptions of organizational attributes, such as decision making, 
leadership, and norms (Ostroff, 2001). Safety climate is a specific aspect of 
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organizational climate, and is defined as employees’ collective perceptions about an 
organization’s commitment to providing a safe work environment (Committee on the 
Work Environment of Nurses and Patient Safety Board on Health Care Services, 2004; 
Cooper & Phillips, 2004). The terms culture and climate are sometimes used 
interchangeably, and they are related. Their relationship is described as follows: “Climate 
follows naturally from culture or, put another way, organizational culture expresses itself 
through organizational climate” (Guldenmund, 2000, p. 221). The distinction is 
important. Culture is an abstract, more “holistic” construct that encompasses the social 
and cultural context of the work situation and is difficult to define (Lymer et al., 2004). 
Climate is a concept that is less abstract and has specific components or dimensions that 
can be described and defined. There are empirical indicators of safety climate that can 
measure those dimensions. Safety culture may be inferred from safety climate, but cannot 
be directly measured. 
Safety climate can be described along a continuum, as positive, neutral or 
negative, depending on workers’ perceived level of the organization’s commitment to a 
safe work environment. Employees of the same organization tend to agree about their 
perceptions of safety climate (D Zohar, 1980) as evidenced by greater variance of safety 
climate scores between workplaces as opposed to within workplaces. Safety climate has 
been studied in industrial settings and found to affect safety performance since the 
1970’s, and recent work indicates that the same relationship of safety climate to safety 
behavior exists in healthcare occupational settings (Dejoy, Gershon, & Schaffer, 2004; 
Stone, Pastor, & Harrison, 2006). 
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There is, however, some disagreement about the components that contribute to a 
better, more positive safety climate. The literature suggests anywhere from three to 
twenty-four dimensions of safety climate (Guldenmund, 2000). For example, Zohar 
(1980) suggested several organizational dimensions based on industrial safety literature, 
and used principle component factor analysis to determine eight important factors. They 
are employees’ perceptions of: 
• Importance of safety training programs 
• Management attitudes toward safety 
• Effects of safe conduct on promotion 
• Level of risk at work place 
• Effects of required work pace on safety 
• Status of safety officer 
• Effects of safe conduct on social status 
• Status of safety committee. 
Cooper and Phillips (2004) adapted Zohar’s questionnaire and determined that 
there are seven dimensions, adding management actions toward safety, while combining 
social status with promotion and status of the safety officer with the safety committee. 
One author (Guldenmund, 2000) suggests that variation in the dimensions making up 
safety climate is likely explained by the difference in industries, populations studied, and 
theoretical model used to frame the research. 
In healthcare organizations, five components have been suggested as indicators of 
a positive safety climate (DeJoy, Murphy, & Gershon, 1995; DeJoy, Searcy, Murphy, & 
Gershon, 2000; Gershon, Stone et al., 2007; Moore et al., 2005): 
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• safety policies and procedures exist and compliance with safety policies is 
expected 
• education and training in safe practice are provided 
• equipment and supplies necessary for safety are made available 
• the organization provides feedback and reinforcement for safety 
• management provides support for safety programs  
It is expected that these aspects of an organization’s safety climate influence 
individual healthcare worker’s adoption of protective behaviors.  The effects of these 
dimensions are described in the following section. 
Safety Policies and Procedures 
The existence of policies related to employee safety is one indicator of a positive 
safety climate (DeJoy, Schaffer et al., 2004). Policies and procedures are overt actions on 
the part of management to affect workplace safety. In several early studies related to the 
use of HD safe handling precautions, the majority of organizations (> 90%) reported 
having written policies regarding HD handling (Mahon et al., 1994; Nieweg, deBoer, 
Dubbleman, & et al., 1994; Valanis, McNeil, & Driscoll, 1991).  Most participants in 
these studies worked in inpatient hospital oncology departments, which were the most 
common setting for cancer treatment at the time. In the 1990’s, economic factors shifted 
cancer treatment to outpatient settings. In a recent study of outpatient and office-based 
oncology settings, Martin and Larson (2003) reported that 85% of outpatient oncology 
treatment settings had written policies for HD handling. Polovich and Martin (2008, 
February) found that only 71% of physician-based oncology practices had written HD 
handling policies, as compared to 90% in all other types of oncology settings. Thus, the 
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shift of treatment from hospitals to other types of organizations has impacted the 
availability of policies related to HD safe handling. 
Policies and procedures requiring the use of personal protective equipment (PPE) 
have been shown to enhance the use of such equipment. For example, overall adherence 
with universal precautions (UP) for protection against blood and body fluid exposure 
increased from 44% to 73% over one year in an emergency department when a policy 
mandating UP compliance was instituted (Kelen et al., 1991). In a study outside of 
healthcare, Mexican factory workers’ use of hearing protection devices (HPDs) in high-
noise environments was 72% - 100% in organizations requiring their use, and 0-27% in 
organizations that did not (Kerr, Lusk, & Ronis, 2002). Nurses who reported double 
gloving for HD handling were significantly more likely to practice in organizations where 
policies required double gloves (Polovich & Martin, 2008, February). The lack of a 
policy mandating the use of protective equipment was given as a reason for not using 
PPE by nurses for HD safe handling (Nieweg et al., 1994; Valanis et al., 1991; Valanis & 
Shortridge, 1987) and by farmers’ for not wearing eye protection (Forst et al., 2006).  
The presence of policies alone, though important, may not lead to appropriate use 
of PPE; the congruence of policies with existing guidelines was also an important 
concern. In two U.S. studies (Valanis et al., 1991; Valanis, Vollmer, Labuhn, Glass, & 
Corelle, 1992), the investigators found that policies requiring PPE for various HD 
handling activities were less stringent than the OSHA (1986) guidelines. In a European 
study, policies were compared to the Netherlands Association of Hospital Pharmacists 
(NAHP) guidelines and fell short of those recommendations (Nieweg et al., 1994). More 
recently, Polovich and Martin (2008, February) found that 52% of respondents’ 
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organizations had not updated their HD safe handling policies to reflect the 
recommendations made by the NIOSH (2004) two years after their publication.  
Individual employees may vary in their compliance with policies. This may be 
due to lack of familiarity with the content of policies. In a study by Nieweg and others 
(1994), 11% of the nurses indicated that there were no guidelines for HD handling in 
their work areas, when in fact all the hospitals involved in the study did have policies. In 
another study (Valanis et al., 1991), nurses incorrectly identified the required PPE for 
certain HD handling tasks. Interestingly, when nurses assumed that specific PPE was 
required by policy, they were more likely to use the PPE, whether or not that was the 
case. The authors in both studies concluded that staff members’ knowledge of their 
facility’s policies was poor. Other reasons for non-compliance are not well understood.  
In summary, policies and procedures are an important aspect of safety climate in 
healthcare organizations. The presence of policies influences workers’ use of protective 
behaviors. However, organizations vary in their activities related to ensuring that policies 
are congruent with current safety recommendations; communicating the content of safety 
policies and procedures; and encouraging compliance with policies.  
Education and Training 
Providing safety training is an important aspect of safety climate. Safety 
education and training affect the adoption of safety-related behaviors. Education refers to 
providing information, while training is defined as forming by “instruction, discipline or 
drill” (Mish, 2004). Safety education provides information to increase knowledge about 
workplace hazards. The effect of knowledge on use of precautions was discussed 
previously. Safety training concerns actions or behaviors that an employee learns to 
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prevent hazardous exposures. In addition to enhancing the knowledge and skills 
necessary for implementing safety precautions, the fact that employers provide education 
and training regarding safety emphasizes its importance to employees.  
Training related to chemical hazards in the workplace is required by the Hazard 
Communication standard (OSHA, 1994) as follows: “at the time of their initial 
assignment and whenever a new physical or health hazard the employees have not 
previously been trained about is introduced into their work area” (p. 470). This training 
must include the health risks associated with the hazards as well as what precautions will 
protect the employee from exposure. Most often, training occurs during orientation of 
new employees. Hospitals generally provide annual updates to comply with requirements 
of other regulatory agencies (e.g., The Joint Commission). Other organizations may vary 
in the type, specificity (e.g., chemicals or drugs), frequency and duration of training.  
Safety knowledge, education and training affect the adoption of safety-related 
behavior. The impact of safety training has been measured in several different 
occupational settings. Training has been associated with safety behavior as measured by a 
safety checklist among manufacturing workers (Cooper & Phillips, 2004); with increased 
use of HPDs by automotive factory workers (Lusk et al., 2003); compliance with UP by 
nurses (DeJoy et al., 1995; Gershon et al., 1995; McGovern, Gershon, Rhame, & 
Anderson, 2000); the use of safe needle precautions among hospital workers (Vaughn et 
al., 2004); and the use of infection control practices by dentists (Gershon, Karkashian, 
Vlahov, Grimes, & Spannhake, 1998).  
The effect of training on the use of HD safe handling precautions is not well-
studied. One study in Israel reported that lack of compliance with safety measures was 
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related to lack of education (Ben Ami, Shaham, Rabin, Melzer, & Ribak, 2001). Two 
studies on HD handling (Martin & Larson, 2003; Stajich, Barnett, Turner, & Henderson, 
1986) reported that nurses had received education about HD handling; however, the 
relationship between training and use of precautions was not evaluated. Little is known 
about what constitutes the most important content of training and what the most effective 
training methods are for increasing the use of HD safe handling precautions.  
Equipment and Supplies 
In order for workers to use appropriate precautions, safety equipment must be 
both available and readily accessible (DeJoy et al., 2000; Moore et al., 2005). In two 
large studies of nurses potentially exposed to blood and body fluids, the availability of 
PPE was a predictor of the nurses’ compliance with PPE (DeJoy et al., 1995; DeJoy et al., 
2000). In one of those studies, PPE availability not only predicted its use, but in 
combination with performance feedback, it accounted for 30% of the variance in a 
measure of safety climate (DeJoy et al., 1995). Moore also suggests that by making 
adequate supplies of PPE readily available, employees may have increased perceptions of 
the effectiveness of PPE in preventing exposure (Moore et al., 2005).  
Nurses have reported that appropriate PPE for HD handling is not always 
available (Martin & Larson, 2003; Polovich & Martin, 2007, March; Valanis & 
Shortridge, 1987). NIOSH recommends that only chemotherapy-tested gloves should be 
used for handling HDs. Despite the availability of chemotherapy-designated gloves for 
over 15 years, Mahon et al. (1994) reported that only 44% of the nurses used the special 
gloves for HD preparation. A more recent study in outpatient chemotherapy settings 
35 
 
(Martin & Larson, 2003) revealed that 84% of nurses mixing HD’s and 60% of nurses 
administering HD’s wore chemotherapy-designated gloves.  
For HD handling, cloth gowns or lab coats are not considered PPE because they 
do not provide protection from chemical penetration. Several studies found that cloth 
gowns were used during HD handling because they were the only protective garments 
available (Mahon et al., 1994; Martin & Larson, 2003; Nieweg et al., 1994; Valanis & 
Shortridge, 1987; Valanis et al., 1992). PPE availability varied with the type of clinical 
setting. Nurses working in private physician office practices where chemotherapy is 
prepared and administered were less likely than nurses working in hospital inpatient or 
outpatient settings to have access to appropriate PPE (Polovich & Martin, 2008, 
February). The organizations’ commitment to safety may be an explanation for the 
variability in availability of PPE and use of precautions. Organizations with a positive 
safety climate both provide appropriate PPE and encourage its use.  
Feedback and Reinforcement for Safety 
Use of safety equipment is often associated with extra work effort, slower work 
pace, and personal discomfort. Because of these barriers, reinforcement for the use of 
safety equipment is necessary. Performance feedback is “social approval or disapproval 
received from coworkers, supervisors and managers” for worker behavior (Dejoy, 
Gershon et al., 2004, p. 51).  
In an interrupted time-series study in an industrial setting, supervisors provided 
regular safety-related interactions, showing approval for safe behavior and disapproval 
for unsafe behavior (Zohar, 2002). This use of feedback resulted in significant changes in 
the minor injury rate, the use of earplugs for hearing protection, and safety climate scores 
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in the experimental group. Feedback has also been associated with a positive safety 
climate and compliance with safety precautions by healthcare workers (Dejoy, Gershon et 
al., 2004; Grosch, Gershon, Murphy, & DeJoy, 1999) and retail workers (Dejoy, Gershon 
et al., 2004). In another study involving healthcare workers, peer feedback improved 
handwashing and glove use for Thai healthcare workers (Moongtui, Gauthier, & Turner, 
2000), although the results were not sustained. Gershon and colleagues (2000) found that 
failure to provide safety-related feedback was related to increased workplace exposure 
incidents. No studies have evaluated safety feedback in settings where HDs are handled. 
Management Support of Safety 
Management support for safety programs has been studied for over thirty years in 
industrial settings; however this has not been well-studied in healthcare settings. DeJoy 
suggests that if workers perceive that productivity is more important than safety 
concerns, unsafe behavior is encouraged (Dejoy, 1986). 
In a small qualitative study of five nurses with self-reported adverse health 
outcomes following occupational HD exposure (Polovich & Minick, 2008), nurses 
discussed barriers that existed in adopting HD safe handling precautions because of 
characteristics of the organizations in which they worked. Lack of knowledge about the 
risks of exposure by persons in authority and monetary issues affected the 
implementation of HD safe handling programs. These nurses reported a general mistrust 
of their employers related to worker safety and believed that lack of PPE, safety 
procedures, and administrative support for HD safe handling programs contributed to 
their HD exposure. They implied that if their employers had been more responsible, they 
might not have experienced adverse health outcomes. Although the sample size was 
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small, this study was the first to suggest the importance of safety climate in use of HD 
safe handling precautions. 
Characteristics of an organization are likely to influence individual worker’s 
behavior related to health and safety. This concept is especially applicable to nurses who 
practice as employees in a health care setting. Activities of organizations that encourage 
safety include having safety goals, allocating resources for safety, having policies that 
promote safety, and providing safety training. Gershon (1995) reported a significant (p < 
.001) positive relationship between ‘perceived organizational commitment to safety’ and 
UP compliance in hospitals and the findings have been consistent across healthcare 
worker populations (Gershon et al., 2000; Gershon, Stone, Bakken, & Larson, 2004). 
HPD use was predicted by positive “union climate” (Raymond et al., 2006) and 
“supervisor climate” for non-Hispanic Whites (Hong et al., 2005; Raymond et al., 2006).  
Lack of an organizational mandate for use of PPE was stated as a reason for 
farmers’ failure to wear eye protection (Forst et al., 2006) and nurses’ failure to use 
appropriate PPE for HD handling (Valanis et al., 1991). Nurses who reported double 
gloving for HD handling were significantly more likely to practice in organizations that 
had updated polices since NIOSH published this recommendation (X2(1) = 17.5, p <.01) 
(Polovich & Martin, 2008, February). 
Several studies have reported lack of availability of appropriate PPE for HD 
handling (Martin & Larson, 2003; Polovich & Martin, 2008, February; Valanis & 
Shortridge, 1987). Spill kit availability and use in the event of a HD spill was 
significantly lower (p = .01) in physician private practice settings than in hospital 
inpatient or outpatient settings (Polovich & Martin, 2008, February). Because both the 
38 
 
availability and use of appropriate equipment and precautions varies by type of setting, 
the organizations’ commitment to safety may be an explanation for this variability. 
Interpersonal Influences on Protective Behavior 
Interpersonal influence refers to the impact of important others’ attitudes toward, 
support for and modeling of a particular behavior. Levin (1999) found that attitudes of 
co-workers toward glove use did not influence glove use for potential blood exposure; 
however, interpersonal influence was found to be a predictor of HPD use in several 
studies (Hong et al., 2005; Kerr et al., 2002; Lusk et al., 1999; Lusk et al., 1997; 
McCullagh et al., 2002). These studies indicate that workers are more likely to use 
protective equipment if their co-workers do. In one study, modeling accounted for more 
variance in HPD use by construction workers than any other predictor (Lusk et al., 1997). 
Interpersonal influences have not been studied in the use of HD precautions. Perceived 
Conflict of Interest  
Health care workers may report a conflict between the need for self-protection 
and the need to provide timely and safe patient care. This type of situational influence is 
unique to health care when staff  work closely with patients and when the exposure risks 
are related to the patients themselves or to patient care. With respect to UP, workers who 
reported high levels of conflict of interest were half as likely to be compliant with UP as 
those who reported low conflict levels (Gershon et al., 1995). This kind of influence has 
not been measured in HD handling, but was suggested in two studies. Nurses reported 
that PPE use “might upset patients” (Valanis & Shortridge, 1987) or “interfere with 
staff’s relationship with patients” (Valanis et al., 1991).  
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Summary 
This study addresses several gaps in the literature.  First of all, although 
researchers have measured how often nurses use HD safe handling precautions in many 
studies over the last twenty years, very few studies have measured the impact of specific 
factors on nurses’ use of HD safe handling precautions. All studies have been descriptive. 
There have only been a few studies examining relationships between PPE use and 
selected characteristics of nurses (age and experience) (Martin & Larson, 2003; Polovich 
& Martin, 2008, February); characteristics of the workplace (type of setting and 
geographical location) (Martin & Larson, 2003; Polovich & Martin, 2008, February); and 
perceived risk (Martin, 2006). Therefore, the use of precautions has been well-
documented, but reasons for using or failing to use HD safe handling precautions have 
not. This study examined theoretical predictor variables—knowledge of chemotherapy 
exposure, perceived risk of harm from HD exposure, self efficacy for PPE use, and 
perceived barriers to PPE use—and their relationship to the use of HD safe handling 
precautions.  
Safety climate, or employees’ collective perceptions about an organization’s 
commitment to providing a safe work environment, is an important factor in the 
occupational safety literature. However, this has never been explored in the area of HD 
safe handling. This study examined the influence of this aspect of organizations on 
nurses’ use of precautions.  
Finally, the notion of a nurses’ need to choose between patient care and use of 
safe handling precautions has been suggested, but not measured. This study evaluated 
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perceived conflict of interest between protecting self and caring for patients as a potential 
moderator of nurses’ use of HD safe handling precautions. 
Since HD safe handling precautions will reduce nurses’ exposure to HDs, it is 
essential to promote their use. This study provides important information about factors 
that affect nurses’ decision to use HD safe handling precautions. 
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CHAPTER III 
METHODOLOGY 
This chapter describes the methods used in conducting the study. The following 
sections are included: research design, sample and recruitment, data collection and 
instruments, study procedures, data management and analysis plan, and methods used to 
protect human subjects. 
Research Design 
A cross-sectional, correlational design was used to determine the relationships 
among nurses’ use of HD safe handling precautions and knowledge about HD exposure, 
perceived risk of harm from HD exposure, self-efficacy for using PPE, barriers to use of 
PPE, organizational influences, interpersonal influences, and perceived conflict of 
interest between protecting self and caring for patients. The interaction effect of nurses’ 
perceived conflict of interest (need to protect self vs. need to provide medical care) and 
self-efficacy for PPE use and the use of HD safe handling precautions were also 
examined. A mail survey method was used to reach nurses who are currently involved in 
handling HDs. In addition, managers’ perspectives on use of safe handling precautions in 
the workplace were explored using a semi-structured telephone interview. 
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Sample and Recruitment 
The participants for the study were registered nurses (RNs) who were employed 
in oncology settings and who reported handling antineoplastic chemotherapy agents 
(preparation, administration, disposal or handling contaminated excreta) in the previous 
year. The exclusion criterion was reporting no chemotherapy handling in the last year. 
Although a random sample is recommended for a correlational design, it was not feasible 
for this study. The population of all U.S. nurses handling HDs was not easily identifiable. 
Using a membership list from the Oncology Nursing Society [ONS] was not appropriate, 
since it is estimated that only 50% of nurses involved in cancer care are members of ONS 
(A. Stengel [ONS Membership Services], personal communication, December 3, 2007). 
In order to include both members and non-members of ONS, oncology nurses were 
identified through their places of employment, using a national sample frame.  
Participants were selected from a membership mailing list purchased from the 
Association of Community Cancer Centers (ACCC). Surveys were mailed to potential 
participants. The Tailored Design Method (Dillman, 2007) was used to increase the 
response rate, which includes multiple contacts with the questionnaire recipient by first 
class mail, the use of a small incentive, stamped return envelopes, and a respondent-
friendly survey. Participant characteristics were obtained, including demographic data, 
years of experience in nursing, information about workplace characteristics, and 
geographic location.  
Another potential source of information about nurses’ use of safe handling 
precautions is the manager or supervisor of nurses who handle HDs. Manager-
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participants identified themselves as holding a formal organizational position where part 
of their responsibility included the supervision of nurses who handle chemotherapy. 
Managers were also recruited by mail using the ACCC mailing list.  
Sample Size 
Required sample size was determined using G*Power (Faul, Erdfelder, Lang, & 
Buchner, 2007). The recommended sample size was 159 participants. This was based on 
performing multiple regression with the eight predictor variables in the conceptual model. 
This sample size should result in sufficient power to detect a moderate effect size of the 
model (power = .80, α = .05, effect size f2 = .10). To achieve the minimum sample size, 
surveys were mailed to 320 nurses to account for non-response, with a target enrollment 
of 160 nurses. In addition, 20 managers were recruited. 
Data Collection and Instruments 
In correlational studies, accurate measurement of variables is essential to the 
validity of the results. Several strategies were used. Because several of the study 
instruments measuring the variables were adapted from tools used with different 
populations, the first step was to assess the validity and reliability of the questionnaires.  
A content validity assessment (CVI) of the questionnaires measuring the predictor 
variables (chemotherapy exposure knowledge, self efficacy for using PPE, perceived 
barriers to using PPE, perceived risk of harm from HD exposure, and workplace safety 
climate) was conducted using an online survey. Three consultants, two with expertise in 
HD handling, and one with expertise in occupational safety and health, scored the 
instruments using the following rating scale for each item:  1 = not relevant, 2 = 
somewhat relevant, 3 = quite relevant, 4 = very relevant. Scores were dichotomized so 
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that items scoring 1 or 2 were considered “not relevant” and those scoring 3 or 4 were 
considered “relevant.” The CVI was calculated using the universal agreement method 
(Polit, Beck, & Owen, 2007) for each item and each scale.  
After the first assessment, several items were revised due to low item-CVI. 
Following a second evaluation, all items had a CVI of 1.0, which Polit and colleagues 
(2007) suggest is appropriate when five or fewer experts assess an instrument. 
The instruments were pilot tested to evaluate them for internal consistency and 
test-retest reliability with a non-random sample of 20 oncology nurses who handle HDs. 
The surveys were administered twice, approximately two weeks apart, and a correlation 
coefficient computed for the relationship between the scores. A Cronbach’s alpha 
measure of internal consistency was also computed. Instruments measuring most of the 
predictor variables performed well in the pilot study, with good to excellent internal 
consistency (.72-.95) and test-retest reliability (.70-.92) (See Table 3).  
The scale measuring chemotherapy exposure knowledge did not perform as well 
in the pilot study. Internal consistency reliability was acceptable (α = .70), but test retest 
reliability was only .35. Scores ranged from 10-12 in both rounds of the pilot study, but 
several individuals improved their scores from time one to time two, resulting in the poor 
test-retest reliability. 
One item (“Reuse of disposable PPE makes me feel less protected”) was removed 
from the Self Efficacy for Using PPE Scale based on low internal consistency in the pilot 
study (Cronbach’s Alpha = .67). Removing that item from the analysis improved the 
internal consistency (α = .83) and test-retest reliability of the scale (R = .69). Because of 
the small number of participants in the pilot study, the item was retained for the larger 
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study, with the intent to evaluate its reliability with a larger sample size. Reliability of the 
7-item scale improved, but remained higher with the six items (α = .79 and .86, 
respectively). Therefore, results from the six-item scale were used for hypothesis testing 
in the final study. An overview of the revised instruments is provided in Table 2. Pilot 
study results are presented in Table 3. The complete study instruments are found in 
Appendix A. 
Table 2 
Overview of Study Instruments 
  
Variables Instrument # Items / Scoring Interpretation
Outcome Measures: 
Safe 
Handling 
Precaution 
Use 
Revised Hazardous 
Drug Handling 
Questionnaire 
Preparation: 6 items 
Administration: 5 items 
Disposal: 5 items 
Excretion: 6 items  
0 = never to 5 = always 
Total precautions (Mean 
score for Admin + 
Disposal) Range 0-5 
Higher score 
indicates 
higher use of 
safe handling 
precautions. 
Predictor Variables: 
Knowledge of 
the Hazard 
Chemotherapy 
Exposure 
Knowledge 
 
12 items: True, False, 
Don’t know. 
Items 3, 6, 8, 9, 11 are 
false; all others true.  
Correct answers=1, all 
others = 0.  
Range: 0-12 (Sum) 
Higher score 
indicates 
higher 
knowledge 
Self Efficacy Self-efficacy for 
Using PPE 
 
6 items, 1 = strongly 
agree to 4 = strongly 
disagree. Items are 
reverse-scored 
Range: 6-24 (Sum) 
Higher score 
indicates 
higher self 
efficacy 
 
(Table 2 Continues) 
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(Table 2 Continued) 
Variables Instrument # Items / Scoring Interpretation
Perceived 
Barriers 
Barriers to Using 
PPE 
 
13 items, 1 = strongly 
disagree to 4 = strongly 
agree. 
Range: 13-52 (Sum) 
Higher score 
indicates 
higher 
perceived 
barriers 
Perceived Risk Risks of 
Chemotherapy 
Exposure 
 
3 items, 1 = strongly 
disagree to 4 = strongly 
agree. Items are 
reverse-scored. 
Range: 1-4 (Mean) 
Higher score 
indicates 
higher 
perceived 
risk 
Organizational 
Influences 
Workplace Safety 
Climate 
 
21 items, 1 = strongly 
disagree to 5 = strongly 
agree 
Range: 21-105 (Sum)  
Higher score 
indicates 
better safety 
climate 
Perceived 
Conflict of 
Interest 
Conflict of 
Interest Scale 
 
6 items, 1 = strongly 
disagree to 4 = strongly 
agree.  
Range: 6-24 (Sum of 
items) 
Higher score 
indicates 
higher 
conflict of 
interest. 
Interpersonal 
Influences 
Interpersonal 
Norms 
 
4 items, importance to 
others of using PPE,  
0 = not at all,  
1 = sort of, 2 = a lot  
Range: 0-2 (Mean)  
Higher score 
indicates 
higher belief 
that others 
think PPE is 
important. 
 Interpersonal 
Modeling 
 
3 items, frequency of 
others’ use of PPE,  
0 = never to 3 = usually 
Range: 0-3 (Mean) 
Higher score 
indicates 
higher use of 
PPE by co-
workers. 
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Table 3  
Pilot Study Results: Total Scale Scores, Cronbach’s Alpha and Test-Test Reliability for 
Predictor Variables 
Scale M (SD) Range Observed Range 
Cronbach’s 
Alpha 
Correlation 
Coefficient 
T1 - T2* 
Chemotherapy 
Exposure 
Knowledge 
11.2 (.77) 0-12 10-12 .70 .35 
Self Efficacy For 
Using PPE 22.9 (3.31) 6-24 11-24 .83 .70 
Barriers to Using PPE 25.6 (5.83) 13-52 13-37 .77 .72 
Risks of 
Chemotherapy 
Exposure 
3.16 (.54) 1-6 2-4.5 .72 .78 
Workplace Safety 
Climate 81.2 (16.89) 21-105 52-105 .95 .86 
Conflict of Interest 
Scale 11.9 (4.18) 6-24 6-21 .89 .70 
Interpersonal 
Influence 1.9 (.58) 0-3 .57-2.5 .91 .92 
Note. Time 2 data collected 2 weeks after Time 1 
Safe Handling Precautions Use 
Nurses’ use of HD safe handling precautions was measured by the Revised 
Hazardous Drug Handling Questionnaire. It is a survey developed by Martin and 
Larsen (2003) and adapted by Polovich and Martin (2008, February). It is based on the 
current guidelines for the handling of HDs (NIOSH, 2004). Following the pilot study, the 
instrument was further revised so that items measuring the use of protective equipment 
were changed from a 3-point scale (usually, occasionally, rarely) to a 5-point scale in 
order to capture additional variability. Additional items were added to distinguish 
between nurses’ use of chemotherapy-designated PPE and other types of PPE. For 
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example, use of “other gloves” and “other gowns” (e.g. not tested for use with 
chemotherapy) were added. 
The final instrument included 25 scored items, which are Likert-type items that 
indicate the frequency of PPE use (5 = Always, 4 = 76-99%, 3 = 51-75%, 2 = 26-50%, 1 
= 1-25% and 0 = Never) for various handling activities. An example is “Please indicate 
how much of the time you use the following when administering hazardous drugs: gloves 
labeled for use with chemotherapy.” Higher mean scores indicate higher use of safe 
handling precautions. Mean scores were determined for safe handling practices and PPE 
use for all handling activities, including drug preparation, drug administration, 
chemotherapy disposal, and handling of excreta. Additional items collected information 
such as the availability of PPE, spill kits, and safe handling policies. 
Knowledge, Self-Efficacy, Barriers and Perceived Risk 
Three subscales from the Occupational Dermal Survey, the knowledge, self-
efficacy, and barriers subscales, and three items about perceived risk (Geer et al., 2007; 
Geer et al., 2006) were used. They were originally developed for dermal chemical 
exposure in the industrial setting, and were adapted for HD exposure in healthcare 
settings. This survey was initially developed based on a literature review of factors 
influencing protective behaviors for dermal chemical exposure. Content validity was 
demonstrated using a panel of experts in industrial hygiene, PPE and survey design. Two 
focus groups of industrial employees who work with chemicals reviewed the instrument 
for face and content validity, and then the scale was pilot tested (Geer et al., 2006).  
The Chemotherapy Exposure Knowledge scale consists of 12 items with the 
response options of true, false, and do not know. Correct answers are scored 1 point and 
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all others are scored 0. The possible range of scores is 0-12. This scale had a Cronbach’s 
alpha of .70 in the final study. 
The Barriers to Using PPE scale is a 13-item Likert scale with four response 
options: 1 = strongly disagree, 2 = disagree, 3 = agree, and 4 = strongly agree. Item 
scores are summed and higher scores indicate higher perceived barriers to PPE use. 
Scores have a possible range of 13-40. Cronbach’s alpha was adequate (.77 in the pilot 
and .88 in the larger study). 
The original survey had two items about perceived risk. The adapted scale 
included six items about perceived risk, which performed well in the pilot study 
(Cronbach’s alpha = .72, test-retest .78). However, in the larger study, only three items 
had good internal consistency reliability (Items 5, 6, and 7). Each was scored 1 = strongly 
disagree, 2 = disagree, 3 = agree, and 4 = strongly agree, and reverse scored so that 
higher scores mean higher perceived risk. Mean scores have a possible range of 1-4. 
Cronbach’s alpha for the 3-item Risks of Chemotherapy Exposure scale was .70. 
Organizational Influence and Perceived Conflict of Interest 
Two subscales of the Healthcare Worker Questionnaire (Gershon et al., 1995; 
McGovern et al., 2000) were adapted for HD exposure for this study. These subscales 
were the Workplace Safety Climate (WSC) questionnaire and the Conflict of Interest 
Scale. The Healthcare Worker Questionnaire was developed to measure compliance with 
UP among HCWs at risk for occupational exposure to bloodborne pathogens. It has been 
used in several different settings, including hospitals, correctional facilities, and non-
hospital based healthcare facilities (Gershon et al., 2005; Gershon, Qureshi et al., 2007; 
Gershon, et al., 1995). Factor analysis was used to assess the construct validity of the 
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Workplace Safety Climate (WSC) scale. It was tested with a sample of 789 hospital-
based healthcare workers. Six organizational dimensions were determined. These are 1) 
PPE and engineering control equipment availability, 2) management support, 3) absences 
of job hindrances, 4) feedback and training, 5) cleanliness and orderliness, and 6) 
minimal conflict/ good communication. Minor changes were made to items to adapt them 
for HD handling (e.g. “chemicals” changed to “chemotherapy”). The items are scored 1 = 
strongly disagree to 5 = strongly agree (Gershon et al., 2000). Item scores are summed for 
a total WSC score. The potential range of scores is 21-105, with higher scores indicating 
a better safety climate. The scale was found to have adequate internal consistency in the 
final study (α = .93). 
Conflict of interest was measured using a 6-item scale adapted from a 4-item 
subscale of the Healthcare Worker Questionnaire. This subscale was originally a part of 
the “barriers to UP compliance” scale. Gershon (1995) reported that the reliability of the 
4-item scale was (α = .72) in a study of HCWs’ use of UP. The reliability of the adapted 
scale was adequate (α = .89) in both the pilot study and the larger study. 
Interpersonal Influences 
Interpersonal influences in the workplace, the impact of others on PPE use, was 
measured using an instrument adapted from McCullagh (McCullagh et al., 2002). The 
instrument measures two aspects of interpersonal influences, interpersonal norms and 
interpersonal modeling. Four items measure a person’s beliefs regarding how much 
others (e.g. co-workers, supervisors) think they should use PPE. Response options are 0 = 
not at all, 1 = sort of, 2 = a lot. Three items measure how often other nurses use 
protective equipment (0 = never to 3 = usually). Higher scores indicate a more positive 
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view of co-worker’s attitudes towards and use of PPE. Mean scores from the two scales 
are combined to obtain an Interpersonal Influence score. Internal consistency reliability 
of the original norms and modeling scales was .75 & .68 with farmers (McCullagh et al., 
2002) and .76 & .86 (Lusk et al., 1997) with construction workers. Reliability of the 
interpersonal influence scale as adapted for HD handling was .91 in the pilot and .80 in 
the larger study. 
Managers’ Perspectives 
The WSC Questionnaire was administered to the managers with instructions that 
they answer items like they thought the nurses they supervise would answer. Managers 
provided additional data through a telephone interview about the safety climate in their 
workplace and the barriers to use of HD safe handling precautions by nurses. The guide 
used for the semi-structured interview is in the Appendix. 
Procedures 
Instrument evaluation and data collection for the study began after obtaining 
approval from the Georgia State University Institutional Review Board. An address list 
was purchased from the Association of Community Cancer Centers. Three hundred nine 
members who identified themselves as nurses were selected for the nurse participant part 
of the study after sorting the list by state. Surveys were sent with a cover letter describing 
the importance of the study and urging nurses to participate. A token of appreciation, a 
$5.00 gift card, was included as an incentive. A pre-addressed, stamped envelope was 
provided for the return of the study instruments. Surveys were labeled with identification 
(ID) numbers linking them to the address of the recipient. This number was used only to 
track responders to identify non-responders for subsequent mailings. A thank-you 
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postcard was sent approximately one week after the original survey, encouraging them to 
respond soon. When surveys were returned, names and addresses were removed from the 
mailing list. Originally, there were to be multiple mailed reminders to the potential 
participants. However, the organization providing the mailing list rented the list for single 
use only. Due to budget limitations, only two mailings per participant were done. 
Additional members were selected from the original list to reach the planned accrual 
goal. 
In addition to the paper study instruments, the questionnaire was made available 
electronically using a secure version of an online survey service. A web address was sent 
in the initial mailing with a link to the online survey.  
Nurse surveys were returned to a post office box obtained for the study. A 
researcher retrieved the surveys from the post office box several times per week during 
the study period. The researcher recorded receipt of the survey by the ID number and 
deleted the participants’ name and address from the mailing list. 
Managers’ Perspectives 
Fifty-two members with titles that indicated they held manager or director 
positions were selected from the mailing list for the manager part of the study. Fifty were 
included in the initial mailing, and 2 additional were mailed to meet the accrual goal of 
20. A cover letter explaining the importance of the study and encouraging them to 
participate was sent. A token of appreciation, a $5.00 gift card, was included as an 
incentive. A pre-addressed, stamped envelope was provided for a response card that 
indicated interest in participating. A web address was sent with a link to a website as an 
alternate way to respond. Letters and response cards were labeled with ID numbers 
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linking them to the address of the recipient. This number was used only to track 
responders to identify non-responders for subsequent mailings. The first fifty potential 
manager participants were also sent an envelope with a nurse survey and gift card, with a 
request that they give it to a nurse who handled chemotherapy in their workplace. A 
thank-you/reminder postcard was sent approximately one week after the original mailing.  
Managers who responded by either mail or online were contacted by a member of 
the research team to schedule a telephone interview. Using telephone interviews rather 
than face-to-face interviews is more cost effective, less time-consuming, allows for 
including study participants from wide geographic areas (Waltz, Strickland, & Lenz, 
2005) and reduces item non-response (Dillman, 2007). Since this plan was to include a 
sample of managers from across the nation, telephone interviews were the most 
appropriate data collection method.  
Interviews were conducted using a semi-structured format, with both closed- and 
open-ended questions. One part of the interview included verbal administration of the 
WSC Questionnaire. Additional open-ended questions were used to elicit more detailed 
information about the concepts of interest. An d was developed to structure the interview 
to encourage each manager-participant to provide an answer to all of the questions. This 
reduced missing data.  
A research assistant served as interviewer and was trained prior to conducting the 
interviews. An interview guide was used that included introductory information, 
complete instructions, the questions, and closing statements. The order of the questions 
was the same for all participants. Probes were provided as needed to encourage complete 
responses. Interviews were audio recorded for accuracy with the consent of the 
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participants. Most interviews were completed in approximately 30 minutes. They were 
scheduled at a time that was convenient to the participants. 
Data Management Plan 
A code book was developed to direct data entry and to determine how ambiguous 
data should be recorded. Data were double-entered, and compared for accuracy. A 
research assistant entered data into Excel, and the data were imported into Statistical 
Package for Social Sciences (SPSS) 17.0 (SPSS Inc., 2008). The original paper surveys 
will be retained for at least one year after completion of the data analysis. Back-up files 
of the data were made and stored after each data entry session. The final copy of the raw 
data will be kept by the researcher indefinitely.  
The recorded interviews were transcribed verbatim using a transcriptionist. The 
answers to the open-ended questions comprised the text for the content analysis.  
Data Analysis 
Data were double entered by two members of the research team, compared for 
accuracy, and errors corrected. Data analysis began with standard data cleaning 
procedures. Patterns of missing data were determined.  Missing data from predictor 
variables (barriers, self efficacy, workplace safety climate, conflict of interest, and 
interpersonal influence) were replaced with the participant scale mean only when less 
than 20% of the total scale data were missing. No missing data were replaced for the 
knowledge scale. Missing data from the outcome variable was replaced with the sample 
mean only when less than 20% of total scale data were missing. The reliability of the 
instruments was evaluated. Prior to hypothesis testing, data were assessed for normality, 
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outliers, and other assumptions of adequate variance, lack of multicolinearity, and 
homoscedasticity. 
Descriptive statistics were used to characterize the distribution of the variables 
and the characteristics of the sample. Frequencies, means and standard deviations were 
determined for all continuous variables. Correlations were computed among the set of 
variables. A significance value of .05 was used for all statistical analyses. 
Analysis for Specific Aims 
The following section contains the approach to statistical analysis based on the 
study questions and hypotheses.  
Specific Aim 1: Determine the influence of individual and organizational factors 
on nurses’ use of safe handling precautions for nurses exposed to HD in their practice.  
Hypothesis 1a: Nurses’ individual characteristics (higher knowledge, higher 
perceived risk of harm from HD exposure, higher self-efficacy for using PPE and fewer 
perceived barriers to using PPE) will be associated with an increased use of HD safe 
handling precautions. Spearman’s correlation coefficient was computed for the 
relationships between use of precautions and chemotherapy exposure knowledge, 
perceived risk, self efficacy and perceived barriers. Significant correlations in the 
expected direction support the hypothesis. A negative relationship between perceived 
barriers and precaution use was expected; all other relationships are positive. 
Hypothesis 1b: Organizational factors (better workplace safety climate and 
interpersonal influences) will be associated with increased use of safe handling 
precautions. Spearman’s correlation coefficient was computed for the relationships 
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between use of precautions, safety climate, interpersonal norms and interpersonal 
modeling. Positive, significant correlations support the hypothesis. 
Hypothesis 1c: Nurses’ individual characteristics (higher knowledge, higher 
perceived risk of harm from HD exposure, higher self-efficacy for using PPE, fewer 
barriers to using PPE) and organizational factors (better workplace safety climate and 
interpersonal influences) will each account for significant variance in use of safe handling 
precautions.  Hierarchical multiple regression was performed with the individual 
predictor variables entered, followed by the organizational variables and examining for a 
significant change in R2. 
Research Question 1d: Does nurses’ perceived conflict of interest (need to protect 
self vs. need to provide medical care) moderate the relationship between self-efficacy and 
use of safe handling precautions? Using hierarchical regression, in the first step, the 
predictor variables were entered. In the second step, an interaction term for self efficacy 
and conflict of interest was entered. A significant change in R2 for the interaction term 
supports the hypothesis. 
Secondary Aim 
To determine nurse managers’ perspectives on use of safe handling precautions in 
the workplace, both interview data and questionnaire data were analyzed. For interview 
data, a content analysis was used, in which the major categories of interest were derived 
from the theoretical model for the study. These were knowledge, self-efficacy, safety 
climate, perceived barriers, perceived risk, interpersonal influence, perceived conflict of 
interest and safe handling precautions. The categories derived from the concepts were 
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defined so that words and phrases could be coded to belong to only one category. 
Categories were added as needed based on the data.  
To answer research question 2a (nurse managers’ perceptions of the 
organizational climate for safe handling precautions), manager’s responses on the WSC 
Questionnaire were analyzed in addition to interview data.   
Protection of Human Subjects 
This study involved nurses who are involved in the preparation or administration 
of hazardous drugs or the care of patients receiving hazardous drugs. The protocol, cover 
letter, manager consent, other correspondence and study instruments were approved by 
the Georgia State University Institutional Review Board (IRB). 
Participants received a token of appreciation with the study instruments as an 
incentive to participate. This was a $5.00 gift certificate to a general store (Wal-Mart). 
Risks to Subjects 
Human Subjects Involvement and Characteristics 
All study participants were RNs age 18 and over who are employed in an 
oncology setting and who report handling antineoplastic chemotherapy agents 
(preparation, administration, disposal or handling contaminated excreta) in the previous 
year. Participants were recruited by mail.  
Sources of Data 
The data obtained by this study was limited to nurse-participant responses to 
questionnaire items. To ensure confidentiality, no survey data contained names or 
personal identifiers. No protected health information was obtained. The completed 
surveys were mailed to a secure post office box. Twenty subjects completed the survey 
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instruments using a secure version of an online survey service. Responses were 
transferred from the paper questionnaires and the online survey to a computer file. All 
survey materials were secured and available only to the research team. (Note: The 
research team consists of the PI, the co-investigator, the research assistant, and the 
transcriptionist). 
Managers’ data were collected by telephone interview.  Interviews were audio 
recorded with the consent of the participants. Participants were reassured that any 
information provided during the interview will be kept confidential. No identifiers were 
used that could connect the participants with their data. Recorded interviews and 
transcriptions were stored in a secure location in the researchers’ office. Recordings were 
not available to anyone other than the research team. 
Potential Risks 
There were no known risks associated with participation in the survey. 
Involvement required about 15-20 minutes of time to complete the survey instruments. 
Providing information about their employer or place of employment may have been 
concerning to some participants. The cover letter assured the participants that they were 
free to stop the survey at any time or to skip any question for any reason.  
There were no known risks associated with the managers’ participation in the 
interview. Involvement required 30-60 minutes of time. Providing information about their 
place of employment may have been concerning to some participants. The consent form 
assured the managers that they were free to stop the telephone interview at any time or 
not respond to any question for any reason. 
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Adequacy of Protection against Risks 
Data collection did not begin until IRB approval was obtained. In a cover letter 
sent with the survey instruments, prospective nurse-participants were informed of the 
study purpose, procedures, risks and benefits, confidentiality, and where to get more 
information. Participation in the study was strictly voluntary. Completing and returning 
the survey instruments constituted consent. Unique identification numbers were used 
only to track responders and non-responders for subsequent mailings. Names and 
addresses of participants were deleted from the mail list when surveys were returned. All 
data were entered without identifying information. The research assistant was instructed 
in confidentiality procedures related to handling of questionnaires. 
For the managers, a consent form was sent to potential participants, which they 
were directed to keep for their records. Verbal consent was obtained by telephone before 
the interview, and participation in the interview constituted consent. 
Potential Benefits of the Proposed Research to the Participants and Others 
Participants received no direct benefit from participating in this study other than 
the token incentive and knowledge of their contribution to information about the factors 
that influence nurses’ use of HD safe handling precautions. 
With a better understanding of the factors that influence nurses’ use of HD safe 
handling precautions, new strategies to improve nurses’ workplace safety related to 
handling HDs may be developed.
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CHAPTER IV  
RESULTS 
This chapter presents the results of this cross-sectional, correlational study to 
determine the relationships among nurses’ use of HD safe handling precautions and 
several theoretical predictor variables (knowledge, self efficacy for PPE use, barriers to 
PPE use, perceived risk of harm from HD exposure, interpersonal influence, workplace 
safety climate, and conflict of interest); and managers’ perspectives on the use of HD safe 
handling precautions by nurses in their workplace. A description of sample characteristics 
and results of hypotheses testing are reported. 
Study Response Rate 
Surveys were mailed to nurses from the ACCC mailing list. The overall response 
rate was 46%. Figure 2 provides details about the nurse survey response.  
 
 
 
 
 
 
 
Mailed Surveys 
(N = 359) 
Excluded (n = 34)  
Returned, undeliverable 
n = 19 (5%) 
Not meeting inclusion criteria 
n = 15 (4%) 
Not Returned 
n = 160 (45%) 
Returned 
n = 165 (46%) 
Figure 2. Response Rate for Nurse Participants
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Nurse Participants 
The majority of nurses were White, female and middle-aged, although ages 
ranged from 23-70 years. Most nurses were very experienced in nursing, oncology 
nursing and chemotherapy handling, reported being an ONS member, and were certified 
in oncology nursing. Most nurses reported practicing in outpatient settings. Nurses 
reported a wide range (0-400) of number of patients receiving chemotherapy per day in 
their practice setting (M = 25.0, Mdn = 18, SD = 35.2), and the average number of 
patients for whom they personally handled chemotherapy per day as = 6.8 (Mdn = 6.0, 
SD = 5.2). Table 4 summarizes the descriptive statistics for characteristics of nurse 
participants in the study.  
Table 4 
 
Nurse Characteristics (n = 163) 
 
Characteristic M (SD) n (%) 
Age (years) 46.4 9.26   
Gender     
 Female   160 (98.2) 
 Male   3 (1.8) 
Experience (years)     
 Nursing 21.2 (9.25)   
 Oncology 15.8 (7.59)   
 Chemotherapy 15.2 (7.62)   
ONS Member (n  = 162)     
 Yes   140 (86.4) 
 No   22 (13.6) 
Nursing Certification  (n = 159)     
 Not certified   21 (13.2) 
 Oncology (OCN, Advanced Oncology)   136 (85.5) 
 Other   2 (1.3) 
 
(Table 4 Continues) 
 
62 
 
 
(Table 4 Continued) 
Race / Ethnicity     
 White   139 (85.3) 
 American Indian/Alaskan Native   2 (1.2) 
 Asian   7 (4.3) 
 Black/African American   7 (4.3) 
 Hispanic/Latino   2 (1.2) 
 Multi-cultural   4 (2.5) 
 Unspecified   2 (1.2) 
Highest Level of Nursing Education     
 Diploma   12 (7.4) 
 Associate Degree   49 (30.1) 
 Bachelor’s Degree   76 (46.6) 
 Masters Degree   24 (14.7) 
 Doctoral Degree   2 (1.2) 
Geographic Location (n = 165)     
 Northeast   43 (26) 
 Southeast   40 (24.2) 
 Midwest   47 (28.5) 
 Southwest   10 (6.1) 
 West   25 (15.2) 
Type of Setting     
 Inpatient   24 (14.7) 
 Outpatient   112 (68.7) 
 Both   27 (16.6) 
Type of Facility     
 Academic health center   7 (4.3) 
 Community non-teaching hospital   56 (34.4) 
 Community teaching hospital   36 (22.1) 
 Private physician office   46 (28.2) 
 Public/government hospital   9 (5.5) 
 Other   9 (5.5) 
Treatment Volume M (SD) Range  
 Number of patients per nurse   6.8 (5.2) 0-35 Mdn = 6 
 Number of patients per practice setting 25 (35.2) 0-400 Mdn = 18
Note: n varied due to missing data. 
Manager Participants 
The desired sample of 20 managers was obtained by mailing fifty-two letters of 
invitation to managers selected from the ACCC mailing list.  Figure 3 provides details 
about the response rate for manager participants. 
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Figure 3.  Response Rate for Manager Participants 
  One manager was a radiation therapist and the others were nurses. The 
majority of managers were White, female and middle-aged, although ages ranged from 
30-70 years. They held titles of manager, director, and supervisor, and two identified 
themselves as clinical nurse specialists with management responsibilities. Managers were 
generally experienced in their role (1-29 years), had up to 49 years of nursing experience 
and were responsible for 10-300 employees (M = 55.6, SD = 63.2, Mdn = 44.5).  The 
majority of managers worked in outpatient settings (80%) where between 2 and 450 
patients received chemotherapy per day (M = 61, SD = 108.5, Mdn = 30). Table 5 
summarizes the descriptive statistics for characteristics of manager participants in the 
study.  
Mailed Letters 
n = 52 
Returned, undeliverable 
n = 2 (4%) 
Not meeting inclusion criteria 
n = 2 (4%) 
No Response 
n = 28 (54%)  
Interviewed 
N = 20 (38%) 
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Table 5 
Manager Characteristics (n = 20) 
 
Characteristic M (SD) Min/Max n (%) 
Age (years) 48.8 (10.2)    
Gender      
 Female    19 (95) 
 Male    1 (5) 
Experience (years)      
 Manager role 9.0 (8.8) 1-29   
 Nursing1 22.4 (11.8) 0-49   
Race / Ethnicity      
 White    16 (80) 
 American Indian/Alaskan Native  1 (5) 
 Black/African American    1 (5) 
 Other/No response    2 (10) 
Geographic Location       
 Northeast    6 (30) 
 Southeast    3 (15) 
 Midwest    6 (30) 
 Southwest    3 (15) 
 West    2 (10) 
Type of Setting      
 Inpatient    4 (20) 
 Outpatient    12 (60) 
 Both    4 (20) 
Type of Facility      
 Academic health center    2 (10) 
 Community non-teaching hospital  10 (50) 
 Community teaching  hospital   6 (30) 
 Private physician office    2 (10) 
Treatment Volume        
 Patients per day 
 (workplace) 61.0 (104.3) 2-450 Mdn = 30 
Min/Max = Observed minimum/ maximum 
1One participant was not a nurse 
Descriptive Statistics for Major Study Variables 
Prior to addressing the hypotheses, data were examined for normal distribution, 
presence of outliers, and missing data. None of the results from the theoretical predictor 
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variables were normally distributed. Results for the Barriers scale and Conflict of Interest 
scales were positively skewed. The results for the following variables were negatively 
skewed: Knowledge scale, Self-Efficacy scale, Perceived Risk scale, Workplace Safety 
Climate scale, Interpersonal Influences scale. Data transformation did not improve the 
distribution. The outcome variable results were normally distributed without outliers. 
Theoretical Predictor Variables 
Table 6 displays the results of all of the instruments measuring the theoretical 
concepts, including chemotherapy exposure knowledge, self efficacy for using PPE, 
barriers to using PPE, perceived risk of harm from HD exposure, interpersonal influence, 
conflict of interest, and workplace safety climate. 
Table 6 
Descriptive Statistics for Theoretical Predictor Variables  
 
Variable M (SD) ObservedRange 
Possible 
Range 
Cronbach’s
Alpha 
Chemotherapy Exposure 
Knowledge 10.9 (1.07) 7-12 0-12 .70 
Self Efficacy for using PPE 20.8 (2.96) 12-24 7-24 .79 
Perceived Barriers 21.94 (6.50) 13-40 13-52 .88 
Perceived Risk 3.14 (.58) 1.6-4 0-4 .72 
Interpersonal Influence 2.21 (.44) .5-3 0-3 .80 
Conflict of Interest 1.83 (.62) 1-3.5 1-4 .89 
Workplace Safety Climate 88.39 (12.03) 60-105 21-105 .93 
 
Knowledge of the Hazard 
 
Total scores on the Chemotherapy Exposure Knowledge scale ranged from 7-12 
(M = 10.9, SD = 1.07), indicating that most nurses were fairly knowledgeable about 
chemotherapy exposure.  The three scale items that nurses lacked knowledge about were: 
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“A surgical mask provides protection from chemotherapy aerosols” [false] for which 
40% of nurses answered incorrectly; and “Chemotherapy cannot enter the body through 
contact with contaminated surfaces [false], and “Alcohol hand sanitizer is as effective as 
soap and water in removing chemotherapy residue” [false] which were each answered 
incorrectly by 15% of respondents.  
Nurses reported high self efficacy for using PPE (M = 20.8, SD = 2.96), and 
moderate barriers to using PPE for HD handling. Four individual items on the barriers 
scale had mean scores at or above the midpoint of the 0-4 scale. These included the 
following items: PPE is uncomfortable (M = 2.4, SD .95); PPE makes me feel too hot (M 
= 2.6, SD 1.0); PPE interferes with job (M = 2.0, SD = .87); and others do not use PPE (M 
= 2.0, SD = .97). 
On average nurses perceived high risk of harm from HD exposure with a mean of 
3.14 on a 4 point scale. Nurses generally reported a low conflict of interest between the 
need to protect themselves and care for patients while handling chemotherapy.  
Based on the Interpersonal Influence scales, nurses perceived that co-workers 
valued and used HD precautions when handling chemotherapy (M = 2.21, SD = .44). 
Nurses rated their employing organization’s commitment to safety high, with an average 
total score of 88.4 (SD = 12.03) on the WSC Questionnaire. 
Nurses’ Use of Safe Handling Precautions 
In the initial data analysis for the use of safe handling precautions two major 
issues were identified.   First, not all nurses participated in all aspects of HD handling and 
the instrument for safe handling had a low reliability coefficient. 
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In this sample not all nurses reported all handling activities. Most nurses reported 
that they administered HDs (99%, n = 164) and disposed of HDs (93%, n = 154), but 
only 73% (n = 120) handled excreta and 19% (n = 32) prepared HDs.  In order to have a 
sufficient sample size for hypothesis testing, the main outcome variable, total HD safe 
handling precautions, was measured using the scales for administration and disposal. 
Data related to the use of HD safe handling precautions for the preparation and handling 
of contaminated excreta scale are reported descriptively but not included in the total HD 
safe handling score.  
To address the second problem of the low reliability coefficient (Cronbach's alpha 
<.60), the scale reliability data were examined. To improve internal consistency, items 
with the lowest item-to-total correlations were removed one by one, until an acceptable 
reliability was obtained.  The items with the lowest item to total correlations were closed 
system transfer devices, “other gloves” (non-chemotherapy labeled) “other gowns” and 
re-use of disposable gowns. The 5 items remaining in each of the administration and 
disposal scales (10 items total) were related to use of chemotherapy gloves, double 
gloves, chemotherapy gowns, eye protection and respirators. The internal consistency 
reliability for these 10 items was adequate, with α = .83. The mean score for these 10 
items was used for the hypothesis testing. Five items make up the mean score for the 
excreta scale, and six items make up the mean score for HD preparation scale (the 5 
above, plus use of biological safety cabinet). These data are reported descriptively. 
As stated above, the total HD precaution use score was defined as the mean score 
for use of chemotherapy gloves, double gloves, gowns, eye protection and respirators for 
HD administration and disposal. Total HD precaution use was 1.9 (SD = 1.1). The 
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possible range of scores was 0-5, with an observed range of 0-5. Table 7 and 8 
summarize safe handling precaution use during the four HD handling activities.  
Table 7 
Means Scores and Standard Deviations for Nurses’ Use of Safe Handing Precautions 
during Various HD Handling Activities 
 Preparation Administration Disposal 
Handling 
excreta 
 
N = 32 
M (SD) 
N = 164 
M (SD) 
N = 154 
M (SD) 
N = 120 
M (SD) 
BSC 4.8 (.87) - - - 
Gloves 4.6 (1.2) 4.0 (1.7) 3.8 (1.9) 2.9 (2.3) 
Double Gloves 1.0 (1.7) 1.2 (1.9) 1.1 (1.8) 1.3 (1.8) 
Gowns 3.5 (1.9) 3.0 (2.2) 2.9 (2.2) 1.9 (2.1) 
Eye Protection 1.5 (2.0) 1.3 (1.7) 1.0 (1.6) 1.2 (1.8) 
Respirator .58 (1.1) .61 (1.1) .59 (1.2) .67 (1.4) 
Overall 
Precautions 2.7 (.76) 2.0 (1.1) 1.9 (1.2) 1.6 (1.3) 
Response options: 0 = Never; 1 = 1-25%; 2 = 26-50%; 3 = 51-75%; 4 = 76-99%;  
5 = Always. Possible range = 0-5 
 
Table 8 
 
Nurses Reporting Use of HD Precautions ‘Always’ or 76-99% of the Time 
 
Precaution 
Preparation
N = 32 
n (%) 
Administration 
N = 164 
n (%) 
Disposal 
N = 154 
n (%) 
Handling Excreta 
N = 120 
n (%) 
Biological Safety Cabinet 31 (97) - - - 
Chemotherapy Gloves 29 (90) 128 (78) 114 (74) 66 (55) 
Double gloves 4 (12) 31 (19) 28 (18) 22 (18) 
Chemotherapy Gowns 20 (64) 92 (56) 82 (53) 36 (30) 
Eye protection 8 (25) 28 (17) 18 (12) 20 (17) 
Respirator/mask 2 (6) 7 (4) 8 (5) 11 (9) 
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Approximately one-fifth of nurses reported that they are responsible for 
chemotherapy preparation. All of these nurses worked in outpatient settings, and most of 
them (n = 27) worked in private physician offices. HD safe handling precaution use was 
high for biological safety cabinets and chemotherapy gloves. Gown use was low and very 
few nurses used double gloves, eye protection or respirators for drug preparation.  
Glove use was high for all handling activities except for handling excreta. Gown 
use was low for all handling activities. Double gloves, eye protection and respiratory 
protection were rarely used by nurses in this sample. Overall precaution use was highest 
for HD preparation (M = 2.7, SD = .76) and lowest for handling HD contaminated excreta 
(M = 1.6, SD = 1.3). 
Relationships Among Nurse Characteristics, Organizational Characteristics, and 
Use of Safe Handling Precautions 
Bivariate correlations were evaluated. Because of the non-normal variable 
distributions, Spearman rank correlation coefficients (rs) were calculated and are reported 
in Tables 9 and 10. Chemotherapy exposure knowledge was not associated with any 
nurse characteristics or organizational characteristics. Higher self efficacy for PPE use 
was associated with more years of nursing and chemotherapy experience, higher 
perceived risk of harm from HD exposure, higher interpersonal influence (co-workers 
valued and used precautions), better workplace safety climate, lower conflict of interest 
and fewer barriers. Fewer barriers to safe handling practices were associated with lower 
conflict of interest, higher self efficacy for PPE use, higher perceived risk of harm from 
HD exposure, higher importance of PPE and use of PPE by co-workers, fewer patients 
per day per nurse, and better workplace safety climate. Lower perceived risk of harm 
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from HD exposure was associated with more years of chemotherapy experience. Higher 
perceived risk of harm from HD exposure was associated with higher importance of PPE 
and use of PPE by co-workers, lower conflict between the need to protect self and care 
for patients, and better workplace safety climate.  Lower conflict of interest between the 
need to protect self and care for patients was associated with more years of oncology and 
chemotherapy experience, higher importance of PPE and use of PPE by co-workers, and 
better workplace safety climate. 
The correlations among nurse characteristics and the theoretical predictor 
variables are displayed in Table 9 and correlations among the theoretical predictor 
variables in Table 10. 
Table 9 
Relationships among Nurse Characteristics, Theoretical Predictor Variables, and Total 
HD Precaution Use 
 
Chemotherapy 
Exposure 
Knowledge 
Self 
efficacy Barriers Risk 
Inter-
personal 
influence
Conflict 
of 
interest 
Total HD 
Precaution 
Use
Age .15 .14 -.50 -.06 .00 .01 .06 
Nursing 
experience1 .03 .21
** -.09 -.11 .10 -.08 .03 
Oncology  
experience1 .03 .29
** -.13 -.15 .13 -.17* .06 
Chemotherapy 
experience1 -.00 .29
** -.14 -.17* .14 -.19* .08 
Patients per 
day (per 
nurse) 
.03 -.11 .23** -.04 -.08 .16 -.28** 
rs = *p < .05,  **p < .01 (2-tailed) 
1Experience in years 
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Table 10  
Relationships among Theoretical Predictor Variables 
 
 Knowledge Self 
efficacy 
Barriers Risk Conflict of 
interest 
Interpersonal
influences 
Knowledge       
Self efficacy .03      
Barriers -.04 -.62**     
Risk .13 .24** -.38**    
Conflict of 
interest .07 -.52
** .68** -.29**   
Interpersonal 
influences -.08 .43
** -.51** .13* -.36**  
Workplace 
safety 
climate 
.07 .67** -.65** .19** -.58** .40** 
rs = *p < .05,  **p < .01 (1-tailed) 
Hypothesis Testing 
There were no significant relationships between total HD safe handling precaution 
use and nurse characteristics, including education level (F (4,158) = .953, p = .44), age (rs = 
.06), nursing experience (rs = .03), oncology experience (rs = .06), and chemotherapy 
experience (rs = .08). Safe handing precaution use was significantly different based on 
facility type. Nurses in private physician offices personally handled chemotherapy for an 
average of 10.7 (SD = 6.0) patients per day compared to 4.5 – 5.0 (SD = 2.9-3.7) patients 
per day in other types of facilities. Analysis of variance and post hoc testing 
demonstrated that the mean patients per day was significantly higher in private physician 
office settings (F (5,152) = 11.8, p <.01). Because there was a relationship between higher 
number of patients per day per nurse (rs = -.28, p < .001) and lower total HD precaution 
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use, this variable was considered a covariate in further analysis. Table 11 reports the 
relationships between HD precaution use and the theoretical predictor variables. 
Table 11 
Correlations between HD Precaution Use and Knowledge, Perceived Risk, Self Efficacy, 
Perceived Barriers, Workplace Safety Climate and Interpersonal Influences 
 Preparation precautions1,2 
Administration 
precautions2 
Disposal 
precautions2
Excretion 
precautions2 
Total HD 
precautions3 
 N = 32 N = 164 N = 154 N = 120 N = 159 
Knowledge -.19 .10 .13 .06 .12 
Perceived risk .18 .21** .18* .10 .21** 
Self efficacy .38* .38** .38** .21* .40** 
Perceived 
barriers -.42
* -.47** -.47** -.24** -.48** 
Workplace 
safety climate .52
** .37** .42** .25** .43** 
Interpersonal 
influences .56
** .23** .21** .22* .24** 
rs = * p < .05  **p < .01 (2-tailed) 
1Biological safety cabinet 
2Chemotherapy Gloves, double gloves, chemotherapy gowns, eye protection and respirators 
3Precautions for administration and disposal only 
 
Hypothesis 1a: Nurses individual characteristics (higher knowledge, higher 
perceived risk of harm from HD exposure, higher self-efficacy for using PPE and fewer 
perceived barriers) will be associated with an increased use of HD safe handling 
precautions. 
Higher chemotherapy exposure knowledge was not significantly associated with 
higher total HD precaution use. Higher total HD precaution use was associated with 
higher perceived risk of harm from HD exposure (rs = .21, p < .01); higher self efficacy 
for using PPE (rs =.40, p <.01); and fewer perceived barriers to using PPE (rs = -.48, p < 
.01). These findings partially support hypothesis 1a. See Table 11. 
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Hypotheses 1b: Organizational factors (better workplace safety climate and 
positive interpersonal influences) will be associated with higher safe handling precaution 
use. 
Higher total HD precaution use was associated with better workplace safety 
climate (rs = .43, p < .01), and positive interpersonal influences (rs = .24, p < .01). These 
findings support hypothesis 1b. See Table 11. 
Hypothesis 1c: Nurses’ individual characteristics (knowledge, perceived risk of 
harm from HD exposure, self efficacy for using PPE, barriers to using PPE) and 
organizational factors (workplace safety climate and interpersonal influences) will each 
account for significant variance in HD safe handling precaution use. Because 
chemotherapy exposure knowledge was not related to total HD precaution use, it was not 
included in the regression model.  The number of patients per day for whom nurses 
personally administered chemotherapy was included as a covariate.  
The initial regression equation included patients per day in step one as a covariate, 
and perceived risk of harm from HD exposure, self efficacy for using PPE, barriers to 
using PPE, workplace safety climate and interpersonal influences in the second step. 
Only two variables (patients per day and workplace safety climate) were significant, with 
barriers having a larger β than workplace safety climate without being significant (p = 
.056). A more parsimonious model including only the significant variables was used. The 
number of patients per day for whom nurses personally administered chemotherapy, 
barriers to PPE use and workplace safety climate were significant (R2 = .29, F(2, 155) = 
24.6, p < .001). In the final model, fewer patients per day, fewer barriers to using PPE 
and better workplace safety climate were associated with higher total HD precaution use, 
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explaining 29% of the variance. Table 12 has the results of the hierarchical regression. 
Hypothesis 1c is partially supported.  
Table 12  
Summary of Hierarchical Regression Analysis for the Variables Predicting Use of 
Hazardous Drug Safe Handling Precautions (N = 159) 
 B SE β t p-value  
Step 1       
 Constant 2.29 .139  16.5 .000  
 Patients per Day -.05 .016 -.24 -3.09 .002  
Step 2       
 Constant 1.20 .96  1.26 .209  
 Patients per Day -.03 .015 -.16 -2.23 .027  
 Barriers -.05 .015 -.28 -3.06 .003  
 Workplace Safety Climate .02 .008 .25 2.80 .006  
Note R2 = .06 for Step 1, p = .002; ∆R2 = .23 for Step 2, p <.001 
Research question 1d: Does nurses’ perceived conflict of interest (need to protect 
self vs. need to provide medical care) moderate the relationship between self efficacy and 
safe handling precaution use? 
Hierarchical regression was performed with Patients per day as a covariate in the 
first step, barriers to using PPE, patients per day, workplace safety climate, self efficacy 
for using PPE, and conflict of interest in the second step, and an interaction term between 
self efficacy for using PPE and conflict of interest in the third step. There was no change 
in R2 following the addition of the interaction between self efficacy and conflict of 
interest. Therefore, conflict of interest did not moderate the relationship between self-
efficacy and total HD precaution use. 
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Research Questions about Nurse Managers’ Perceptions of Safe Handling 
Precautions 
Research Question 2a: What are nurse managers’ perceptions of the 
organizational climate for safe handling precautions? 
Research Question 2b: For nurses they supervise, what are nurse managers’ 
perceptions of nurses’ use of safe handling precautions?  
Written policies regarding HD safe handling precautions were present in 100% of 
workplace settings, according to the managers. All policies addressed the following 
aspects of chemotherapy handling: required qualifications of personnel for chemotherapy 
handling; required personal protective equipment for chemotherapy handling; procedures 
for chemotherapy disposal; procedures for transporting chemotherapy; and procedures for 
HD spill management. Two aspects of HD handling were not always addressed in policy. 
Sixteen (80%) organizations had policies that address acute exposure management, and 
only nine (45%) addressed health monitoring of personnel who handle HDs. Policies 
developed by multidisciplinary committees included all recommended elements. Policies 
addressed exposure management and health monitoring in organizations where safety 
officers and employee health professionals were included in policy development and 
review.  
All managers reported that there were existing written policies that addressed PPE 
use in their organization; however, five of 20 organizations did not require staff to wear 
gowns during HD handling. One manager reported that gown use was not required by 
OSHA guidelines, when in fact gowns have been recommended by OSHA since 1986.  
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Most orientation programs for chemotherapy handling included classroom 
education and supervised practice with a preceptor. Sixty percent of managers reported 
using a skill checklist during orientation that included HD precautions. Five (25%) of 20 
practice settings had a formal mechanism in place for ongoing monitoring of nurses’ 
compliance with safe handling policies; ten reported using informal “spot checks” to 
monitor nurses’ use of HD precautions; and five sites (25%) had nothing in place to 
monitor nurses’ safe handling precaution use.  
When the managers were asked why the nurses they supervised might not wear 
gowns or gloves for HD handling, three managers reported that there was good 
compliance with PPE in their setting.  Other managers cited the following reasons for 
nurses not wearing PPE: gowns not provided by employer (5); too busy or rushed (5); 
gowns uncomfortable or cumbersome (4); lack of concern for exposure (4); urgent patient 
situations (3); lack of knowledge (3); forgetting (3); poor fitting gloves (1); concern for 
cost containment (1); patients’ objections (1); and precautions “too extreme” (1). 
One manager stated emphatically that patients object to nurses wearing gowns, 
because they do not understand why nurses are “afraid of a drop” of chemotherapy. 
Another stated that “there’s noncompliance if you require gowns.” One manager, who 
personally handled chemotherapy, admitted not wearing a gown for years because of 
discomfort. Another expressed that recommended precautions are too “extreme” and 
should be more realistic.  
Managers scored 67-104 (M = 92.7 ± 8.6, (potential score = 21-105; Cronbach’s 
alpha = .92) on the WSC questionnaire, indicating a positive workplace safety climate.  
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Summary 
This chapter presented the results of a cross-sectional, correlational study to 
determine the relationships among nurses’ use of HD safe handling precautions and 
several predictor variables and managers’ perspectives on the use of safe handling 
precautions in the workplace. A description of participants’ characteristics, findings from 
the questionnaires and results of hypothesis testing were reported. 
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
Chapter V presents a discussion of the study results and the conclusions regarding 
the hypotheses. This chapter concludes with a discussion of the limitations, implications 
for practice, theory development and future research. 
This study adds to the limited body of knowledge about factors influencing the 
use of HD safe handling precautions. Previous studies have focused on the frequency of 
HD precaution use and some individual factors that are associated with HD safe handling 
precaution use. This study was not the first to study organizational factors influencing 
HD safe handling precaution use, but it is only the second to measure their impact on use 
of HD handling precautions.  In a study over 15 years ago, Valanis and others (1991) 
reported that the presence of hospital policies increased HCW’s use of HD safe handling 
precautions.  The use of HDs has become more widespread with administration in 
different settings and for non-oncology indications, such as the autoimmune disorders 
rheumatoid arthritis, lupus nephritis, and multiple sclerosis, increasing the importance of 
promoting the use of safe handling precautions in all settings where HDs are given. 
Evaluation of HD Safe Handling Precaution Use 
Overall, in this sample of nurses who were knowledgeable about HD use, 
experienced in handling chemotherapy, confident in how to use safe handling 
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precautions, and who perceived HD exposure to be a risk to their health, use of HD safe 
handling precautions was low. Every HD handling activity represents an opportunity for 
exposure, and when precautions are not used, the likelihood of exposure increases. The 
most frequently used precaution was biological safety cabinets for HD preparation and in 
this sample most nurses were not involved in preparing HD for administration. The 
second most frequently used precaution was wearing chemotherapy gloves for most 
handling activities. Although these precautions are important, they are insufficient to 
prevent HD exposure in all situations. As exposure increases, the chance for adverse 
health outcomes increases. Currently, few organizations have programs for monitoring 
health effects of HD exposure, which was consistent with reports from managers in this 
study, making the adverse health effects from HD exposure less likely to be recognized 
and documented.  This differs from other health threats in the workplace such as hepatitis 
B exposure, tuberculosis exposure, and radiation exposure, where health care workers are 
monitored regularly.  Without data on the exposure to HDs, the full impact of this 
exposure may not be realized.  Routine medical surveillance of nurses involve in HD 
handling activities could provide important data about exposure.  
In testing the model relationships, individual nurse characteristics were not 
associated with HD safe handling precaution use, whereas organizational characteristics 
were.  This has important implications since factors in the workplace environment seem 
to be the most salient concepts affecting safe handling practices.  An unexpected finding 
was that a higher number of patients per day per nurse was associated with lower use of 
HD safe handling precautions.   
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Several authors (Geer et al., 2006; Mahon et al., 1994; Valanis et al., 1991; 
Valanis & Shortridge, 1987) have reported that workers cite time pressure or lack of time 
as one of the barriers to PPE use across occupational settings.  Based on the findings in 
this study, that seems to be an accurate assessment. The number of patients assigned to a 
nurse in a day, an objective measure of workload, interfered with HD precaution use. The 
lack of time was also a reason cited by managers in this study about reasons why nurses 
may not use PPE for HD handling in their setting. 
Not only has chemotherapy administration moved to outpatient settings over the 
last twenty years, but treatment has also migrated away from hospitals to physician 
private practices. In this study, nurses working in physician private practice settings cared 
for the highest numbers of patients per day—twice that of nurses working in other 
settings. It is important to determine the optimal workload for nurses handling 
chemotherapy that allows sufficient time for use of safe handling practices.  The number 
of patients assigned to a nurse each day for administration of HD is a workplace 
characteristic over which nurses have little control. Managers of nurses where 
chemotherapy is handled must carefully consider workload, not only for safe patient care, 
but also to reduce interference with nurses’ use of HD safe handling precautions. 
The use of HD safe handling precautions while handling contaminated excreta 
was the poorest, with nurses reporting overall use of PPE less than 50% of the time. Since 
Universal Precautions (UP) also require barrier precautions for handling blood and body 
fluids, this low compliance is difficult to explain. Although most nurses administered and 
disposed of HD routinely, the overall use of safe handling precautions was lower for 
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administration of HD than for preparation of HD which few nurses were involved in, and 
lower still for disposal and handling patient excreta.  The low use of HD safe handling 
precautions in handling patient excreta may be due to a reduced concern for exposure 
because of perceptions about the lower concentration of HDs in body fluids. In 
ambulatory settings, it may be that excreta handling is not required as frequently, since 
patients are more likely to toilet independently. PPE may not be conveniently located to 
facilitate ease of use. Poor use of HD safe handling precautions for handling excreta may 
be related to lack of knowledge about drug residue in excreta, but that is unknown in this 
sample since the Chemotherapy Exposure Knowledge scale did not measure knowledge 
about contaminated excreta. Another possible explanation is that this aspect of HD 
handling may not emphasized in education in these settings. 
Individual Predictors 
Chemotherapy exposure knowledge was not related to use of HD safe handling 
precautions. In this study, the lack of relationship between knowledge and the other 
theoretical predictor variables is likely due to the lack of variance in this factor. The vast 
majority of the nurses answered all of the questions correctly.  This indicates that the 
knowledge scale used may need to be revised to better discriminate chemotherapy 
exposure knowledge levels.  However, even with this high knowledge level, HD safe 
handling precaution use was poor, indicating that knowledge alone is insufficient to 
ensure HD precaution use.  
These findings concerning the relationship between knowledge and precaution 
use are inconsistent with earlier studies.  Ben Ami and colleagues (2001) found that 
82 
 
 
failure to comply with HD safe handling precautions was related to lack of education and 
Harrison found improved use of precautions following education (Harrison, et al., 1996). 
The study samples were obtained from one or two institutions, and one study was set in 
Israel. Since both of the previous studies were conducted some time ago, it may be that 
HCW knowledge about chemotherapy exposure has improved over the years. The current 
study had representation from all regions in the U.S. which is more representative than 
several earlier studies about HD use (Mahon et al., 1994; Stajicj et al., 1986; Valanis et 
al., 1991).  
Although nurses’ perceived risk of harm from HD exposure was related to higher 
total HD precaution use, it was not a predictor in the final regression model. Interestingly, 
lower perceived risk of harm from HD exposure was associated with more years of 
chemotherapy experience. It is unclear if more years of experience was related to a 
decreased concern about the occurrence of exposure or a decreased concern about the 
potential adverse outcomes of exposure. Lower perceived risk of harm from HD exposure 
was associated with lower gown use in a previous study (Martin, 2006). Other authors 
(Gershon et al., 1995; Levin, 1999) have reported a positive relationship between 
perceived risk and UP use. Those findings were based on simple correlations and not 
tested with more advanced statistical tests incorporating multiple variables.  
Nurses were more confident about their ability to use HD safe handling 
precautions with more years of experience and when their co-workers valued and used 
precautions. Self efficacy for using PPE was higher for nurses who reported better 
workplace safety climate and fewer barriers to using PPE, but higher self efficacy for 
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using PPE was not associated with HD safe handling precaution use in the final model. 
Factors in the workplace were more salient for nurses’ use of HD safe handling 
precautions. Self efficacy may be a more important concept for behaviors where 
individuals have more control over the situation.  
Nurses reported lower conflict of interest between protecting self and providing 
patient care when their co-workers valued and used precautions and when they worked in 
a better workplace safety climate. Nurses who did not perceive a conflict between their 
own safety and patient needs reported higher total HD precaution use. In a study of UP 
use (Gershon et al., 1995), workers who reported high levels of conflict of interest 
between caring for themselves and their patients were half as likely to use UP as those 
who reported low conflict levels. This was the first study to measure the effect of conflict 
of interest on HD safe handling precaution use, although it’s influence was suggested in 
two early studies (Valanis et al., 1991; Valanis & Shortridge, 1987). Although conflict of 
interest between self protection and caring for patients did not account for any variance in 
HD precaution use in this sample, lower conflict of interest was associated with a better 
workplace safety climate, more confidence in using PPE, and fewer barriers.  This may 
be additional evidence that a strong emphasis on workplace safety may convey that the 
health and safety of the nurse (worker) is as important as the patient’s care.  Safety 
climate and interpersonal influences reflect workplace influences on behavior. The study 
findings suggest that actions and attitudes of co-workers and other workplace issues can 
influence whether or not nurses experience a conflict between protecting themselves from 
HD exposure and providing patient care.  
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Organizational Factors 
This study is the first to investigate the relationship between workplace safety 
climate and HD safe handling precaution use.  A better workplace safety climate was 
associated with better HD safe handling precaution use by nurses. This finding is similar 
to Gershon’s findings in studies of UP compliance in hospitals and other HCW 
populations (Gershon et al., 2000; Gershon et al., 2004). Only barriers to using PPE had a 
stronger association with HD precaution use. 
Initially, it was assumed that nurses in the sample would be responsible for all HD 
handling activities except for HD preparation.  Previous studies have not always asked 
nurses to respond about whether they perform these functions, and thus measured more 
general use of safe handling precautions.  In this study, precaution use varied with the 
handling activity, suggesting that nurses may consider the activities separately when 
deciding whether or not to use protective equipment.  While NIOSH recommends a 
“universal precautions approach” to HD handling (2004, p. 31), this has not happened.  
Few nurses in the current study sample prepared chemotherapy, but precaution 
use for preparing chemotherapy was better than for other handling activities. Our findings 
clearly indicate that precaution use for HD administration, disposal and handling of 
contaminated excreta is below recommendations and this must be addressed.  
This study included the manager’s perspectives of the organizational safety 
climate.  Managers reported that their organizations have policies related to HD safe 
handling precautions; however, the policies were not always reflective of the scope of the 
current OSHA, ONS, ASHP, and NIOSH recommendations. Some managers indicated 
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that HD safe handling policies had been developed by an interdisciplinary group, and 
those policies addressed all recommended safe handling precautions. Interdisciplinary  
safety committees are a characteristic of organizations where worker safety is valued, and 
reflects a better workplace safety climate. 
Limitations of the Study 
The study findings must be considered in the context of some limitations. The 
first limitation is related to the representativeness of the sample. The sample size was 
adequate to power the study; however, the sample may not be representative of all nurses 
handling chemotherapy.  Participants were recruited using the ACCC membership list 
with the plan to recruit both ONS and non-ONS members. Despite this strategy, 86% of 
study respondents reported being ONS members, whereas it is estimated that only 50% of 
oncology nurses belong to ONS. While the age and racial diversity of the sample was 
similar to that of nurses in the U.S., men were underrepresented. A large number of study 
participants were certified in Oncology Nursing, which may make their responses 
different from non-oncology certified nurses.  
The second limitation relates to the study instruments. Since several of the 
questionnaires were adapted for the study, this is the first time they have been used in 
nurses responsible for HD handling. The Chemotherapy Exposure Knowledge 
questionnaire requires further refinement so that it can distinguish between levels of 
knowledge related to the concept. There are no questions related to exposure to 
contaminated excrement, for example, since the instrument was originally developed for 
chemical exposure in industrial settings where workers do not handle excreta. Low 
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knowledge about the potential for HD exposure related to handling excreta may have 
helped to interpret the poor HD safe handling precaution use for that handling activity. 
The perceived risk scale did not measure some potentially important aspects or risk, such 
as immediacy and frequency of adverse outcomes.  The conflict of interest scale has only 
been used in two studies, and should be tested in larger samples to establish validity and 
reliability. 
Strengths of the Study 
This study had several strengths. First, it used a national sampling frame to 
increase representativeness of the sample of oncology nurses handling chemotherapy. 
Second, this study was the first to evaluate relationships between organizational factors 
and nurses’ use of HD safe handling precautions.  Third, no other study to date has 
included the managers of nurses who handle HDs. While the sample of managers was 
small, the results provide a unique perspective about the impact of workplace safety 
climate on nurses’ use of HD safe handling precautions. Finally, this study adds to the 
knowledge about nurses’ use of HD safe handling precautions by moving beyond a 
descriptive design to a correlational design, which represents an advancement in the 
understanding of the phenomenon.  
Implications for Practice 
As the use of antineoplastic and other HDs increases, more nurses are potentially 
exposed as they provide patient care.  Based on the study findings, the workplace climate 
created by the organization is very important in the routine activities of nurses. This 
indicates a very different focus for efforts to improve nurses’ HD precaution use.  
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Managers need to be versed in the HD handling safety requirements in order to develop 
and support safe handling policies.  In this study, not all managers were familiar with 
current recommendations for HD safe handling. Some managers minimized the 
importance of nurses complying with HD safe handling precautions, and few had a 
formal mechanism in place to monitor nurses’ use of PPE. 
Current strategies to improve HD precaution use have stressed education to 
increase chemotherapy exposure knowledge. Nurses must be knowledgeable about the 
potential adverse outcomes from HD exposure and how to prevent exposure. Education is 
a necessary component for precaution use, especially for nurses new to chemotherapy 
handling.  However, even nurses who are knowledgeable and confident in their ability to 
use HD safe handling precautions may not always use safe handling precautions without 
specific expectations in the work setting.  Much of the previous research has focused on 
the influence of individual nurse characteristics on whether nurses used safe handling 
precautions instead of the influence of the workplace. We know from research in UP that 
the workplace has a strong influence (Gershon et al., 2000; Gershon et al., 1999; Gershon 
et al., 1995) and this is a fruitful area of inquiry.  
Findings from this study indicate that because circumstances in the workplace 
interfere with use of precautions, organizational factors must be considered if HD safe 
handling precaution use is to improve. Three specific factors—barriers to using PPE, 
workplace safety climate and patients per day—are organizational factors that are related 
to and likely to have an impact on use of HD safe handling precautions. 
88 
 
 
One barrier to HD precaution use is availability of PPE. Nurses cannot use PPE 
unless it is available, and providing PPE that is appropriate to a hazard is the employers’ 
responsibility. Supervisory personnel may be unaware of the need for precautions or may 
not support precaution use. Adequate supplies of gowns, gloves, and other protective 
equipment must be provided and its use must be encouraged (DeJoy et al., 1995; DeJoy 
et al., 2000; Moore et al., 2005).  
Encouragement for using PPE is a component of workplace safety climate. 
Studies in other populations have reported the definite influence of supervisors providing 
positive feedback and reinforcement for safe practices (Dejoy, Gershon et al., 2004; 
Grosch, Gershon, Murphy, & DeJoy, 1999; Dov Zohar, 2002). Nurses must not be sent 
actual or implied messages to limit PPE use, which is negative reinforcement for 
precaution use. Our findings suggest that supervisors’ support for and encouragement of 
HD precautions will increase their use.  
Budget and staffing may interfere with consistent HD safe handling precaution 
use.  Since patient care workload impacts nurses’ use of precautions, the number of 
patients assigned to a nurse is an important consideration. This may create a conflict for 
organizations, since staffing ratios have an economic impact on the organization.  Nurses 
caring for patients receiving chemotherapy should not be too busy to take time to protect 
themselves from HD exposure. This study provides evidence for the influence of nurse-
patient ratio on nurse safety.  
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Implications for Theory Building 
Based on these study findings, the model components are insufficient to explain 
HD safe handling precaution use. In this study, nurses’ individual characteristics were not 
associated with HD safe handling practices, as proposed in the PHDP model.  It may be 
that the individual nurse characteristics have an indirect relationship with HD safe 
handling precaution use, but this was not evaluated.  Future research with larger samples, 
using more sophisticated statistical analysis such as structural equation modeling may be 
helpful in elucidating relationships. 
This model was adapted from one used to explain workers’ use of hearing 
protection.  There are differences in that use of hearing protection devices requires only 
the insertion of ear plugs or the use of ear muffs.  Use of HD safe handling precautions is 
more complicated in that it requires selecting several pieces of protective equipment from 
among different types designated for different purposes (e.g. blood and body fluids 
precautions or HD protection). Eye and respiratory protection are cumbersome and 
uncomfortable. Additionally, HD precaution use occurs in the context of caring for 
patients, so is not a fully independent activity. These may be reasons why the influencing 
factors differ with the specific type of self-protective behavior. 
Further study in larger samples may identify additional variables and 
relationships.  Different theories related to motivation or theories of organizational 
behavior may be more useful in addressing HD safe handling practices.   
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Implications for Research 
The findings of this study suggest several suggestions for future investigation. 
First, this study should be replicated using a larger, more representative sample of 
chemotherapy nurses. Little is known about HD precaution use among non-ONS 
members, since most studies have not included these nurses. It remains an unanswered 
question. 
Secondly, additional research is needed to discover other factors that are relevant 
to HD precaution use, since the factors in PHDP model were inadequate. Continued 
model development using path analysis and structural equation modeling may refine the 
relationships among the predictors. 
Since fewer barriers to using HD safe handling precautions were a strong 
predictor of safe handling precaution use, future research should address ways of 
reducing barriers.  Some identified barriers that interfere with HD precaution use are 
related to the discomfort of wearing PPE are difficult to overcome; however, involving 
staff members in the evaluation and selection of PPE may be one effective strategy. 
Managers of nurses who handle HDs are an appropriate population for further 
study, since they can have a strong influence on nursing practice in their setting. The 
impact of positive reinforcement of HD safe handling precaution use by supervisors 
should be evaluated. This type of intervention has not been studied in HD safe handling, 
and may provide useful information. In addition, managers may identify opportunities for 
improvement in PPE use by implementing systematic methods of evaluation of HD safe 
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handling precautions that includes checklists as well as random observations of nurses’ 
practice on their units. 
Conflict of interest is a concept unique to HCWs that has not been fully explored. 
Two early studies suggested that conflict of interest may interfere with HD safe handling 
precaution use (Valanis et al., 1991; Valanis & Shortridge, 1987). The managers in this 
study listed “urgent patient situation” and “patient objections” as reasons nurses may not 
use PPE, which are indications that the concept is relevant in this population. Its effects 
on precaution use should be further studied in oncology nursing. The scale that was used 
in this study to measure the concept requires additional development. 
Finally, since HD precaution use other than gloves is below current 
recommendations, it is essential to evaluate both the occurrence of exposure and its 
biological effects. There is currently no registry of data connecting nurses’ exposure 
history and health outcomes. A longitudinal, epidemiological study of oncology nurses, 
comparing HD-exposed and unexposed nurses, is essential to quantify the occurrence of 
adverse effects from HD exposure.  Studies that include objective measures of HD 
exposure, for example using urine samples, may be helpful in identifying the extent of 
exposure.  New methods of evaluating the biological consequences of occupational 
exposure to HDs are essential. 
Conclusions 
This study adds to the body of literature regarding oncology nurses’ use of HD 
safe handling precautions. Nurses have often been held entirely responsible for their own 
practice, including the use of HD safe handling precautions. These study findings 
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emphasize the influence that organizations have on nurse’s adoption of self-protective 
behaviors; it is clear that safe practice is a shared responsibility between employers and 
nurses.  
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Federal regulations require researchers to follow specific procedures in a timely manner.  For the 
protection of all concerned, the IRB calls your attention to the following obligations that you 
have as Principal Investigator of this study. 
 
1. When the study is completed, a Study Closure Report must be submitted to the IRB.   
 
2. For any research that is conducted beyond the one-year approval period, you must 
submit a Renewal Application 30 days prior to the approval period expiration.  As a 
courtesy, an email reminder is sent to the Principal Investigator approximately two 
months prior to the expiration of the study.  However, failure to receive an email 
reminder does not negate your responsibility to submit a Renewal Application.  In 
addition, failure to return the Renewal Application by its due date must result in an 
automatic termination of this study.  Reinstatement can only be granted following 
resubmission of the study to the IRB. 
 
3. Any adverse event or problem occurring as a result of participation in this study must 
be reported immediately to the IRB using the Adverse Event Form. 
 
4. Principal investigators are responsible for ensuring that informed consent is obtained 
and that no human subject will be involved in the research prior to obtaining informed 
consent.  Ensure that each person signing the written informed consent form (ICF) is 
given a copy of the ICF.  The ICF used must be the one reviewed and approved by 
the IRB; the approval dates of the IRB review are stamped on each page of the ICF.  
Copy and use the stamped ICF for the coming year.  Maintain a single copy of the 
approved ICF in your files for this study. 
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All of the above referenced forms are available online at https://irbwise.gsu.edu.  Please do not 
hesitate to contact Susan Vogtner in the Office of Research Integrity (404-413-3513) if you have 
any questions or concerns. 
 
Sincerely, 
 
 
 
Susan K. Laury, IRB Chair 
 
 
 
 
 
 
Federal Wide Assurance Number:  00000129 
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Thank you for agreeing to participate in this study of nurses who handle chemotherapy. 
“Handling” refers to chemotherapy preparation, administration, disposal, and coming into 
contact with patient’s excreta that may be contaminated with chemotherapy.  
 
• By preparation, we mean transferring chemotherapy drugs from vials or ampoules to 
syringes or IV containers.  
• By administration, we mean giving chemotherapy to patients by IV, injection, orally, etc. 
• By disposal, we mean discarding equipment used in chemotherapy preparation or 
administration. 
• By handling excreta, we mean emptying bedpans, urinals or emesis basins. 
 
Do you personally handle chemotherapy at work, either chemotherapy preparation or 
administration? 
 
  Yes 
  No → If you answered “No” STOP HERE and return the questionnaire.  
 
If you answered “Yes”: 
 
1. Please enter the ID number that is printed on the study 
letter: 
2. Please read each item carefully 
3. Place a check in the box next to your selection from the list of options 
4. Please answer all of the questions that apply to your chemotherapy handling. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ID Number 
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Section 1 
 
Select one answer to each of the following statements about chemotherapy exposure. 
 True False Don’t Know 
1. Chemotherapy can enter the body through breathing it in       
2. Chemotherapy can enter the body through ingesting it       
3. Chemotherapy cannot enter the body through contact with 
contaminated surfaces 
      
4. Chemotherapy can enter the body through contact with spills and 
splashes 
      
5. Chemotherapy gas and vapor in air can enter the body through 
skin and mucous membranes 
      
6. Oral forms of chemotherapy do not have the potential to be 
absorbed 
      
7. Chemotherapy in liquid form can be absorbed through the skin       
8. A surgical mask provides protection from chemotherapy aerosols       
9. All types of gloves provide the same level of protection       
10. Chemotherapy can more easily enter the body through damaged 
skin 
      
11. Alcohol hand sanitizer is as effective as soap and water in 
removing chemotherapy residue 
      
12. Chemotherapy can enter the body through contaminated foods, 
beverages, or cosmetics 
      
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Section 2 
Indicate your level of agreement with each of these statements about using personal protective 
equipment (PPE) when handling chemotherapy. 
SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree: 
 SA A D SD
1. I am confident that I can use PPE properly         
2. I am confident that I can protect myself from chemotherapy exposure          
3. I am given enough information on how to protect myself from 
chemotherapy exposure         
4. My supervisor goes out of his/her way to make sure I am protected         
5. Reuse of disposable PPE makes me feel less protected         
6. I am provided with the best available PPE         
7. My supervisor goes out of his/her way to make sure I am provided 
with proper fitting PPE         
 
Section 3 
Does your workplace have written policies and/or procedures for handling chemotherapy? 
  Yes 
  No 
Where is chemotherapy prepared in your workplace?  
 Pharmacy   
Drugs are delivered to the infusion area (prepared in an off-site 
location) 
  
 Specially designated room separate from the patient care area   
 Area within the patient treatment area / room   
 Other (specify) ________________________   
What personal protective equipment is available for performing the following 
chemotherapy handling activities? Check all that apply.
 Gloves Gowns Eye  
Protection 
Respirator/ 
Mask 
Preparation         
Administration         
Handling Excreta         
Disposal         
Cleaning Spills          
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Section 4  Chemotherapy Preparation: 
Are you responsible for preparing chemotherapy? 
  Yes    No → If you answered “No” proceed to Section 5. 
Complete this section ONLY if you prepare chemotherapy drugs.  
What type of gloves do you wear while preparing chemotherapy? 
 None   
 Chemotherapy designated gloves   
 Vinyl (polyvinyl chloride, PVC)   
 Latex examination gloves   
 Sterile surgical gloves   
 Other (specify) ____________________   
What type of protective clothing do you wear while preparing chemotherapy?  
(Check all that apply.) 
 None   
 Chemotherapy-designated gown   
 Personal lab coat   
 Lab coat provided by office   
 Cloth gown   
 Isolation gown   
 Other (specify) _____________________   
Please indicate how much of the time you use the following while preparing chemotherapy:  
 Always 76-99% 51-75% 26-50% 1-25% Never 
Biological Safety Cabinet             
Closed system transfer device             
Gloves labeled for use with chemotherapy             
Other gloves (e.g. vinyl)             
Double gloves             
Gowns labeled for use with chemotherapy             
Other gowns (e.g. cloth)             
Do you re-use disposable gowns?             
Eye protection             
Respirator/mask             
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Section 5 Chemotherapy Administration:  
 
Are you responsible for administering chemotherapy? 
  Yes    No → If you answered “No” proceed to Section 6. 
 
Complete this section ONLY if you administer chemotherapy.  
What type of gloves do you wear while administering chemotherapy? 
 None   
 Chemotherapy designated gloves   
 Vinyl (polyvinyl chloride, PVC)   
 Latex examination gloves   
 Sterile surgical gloves   
 Other (specify) ____________________   
What type of protective clothing do you wear while administering chemotherapy?  
Check all that apply. 
 None   
 Chemotherapy-designated gown   
 Personal lab coat   
 Lab coat provided by office   
 Cloth gown   
 Isolation gown   
 Other (specify) _____________________   
Please indicate how much of the time you use the following while administering chemotherapy 
 Always 76-99% 51-75% 26-50% 1-25% Never 
Closed system transfer device             
Gloves labeled for use with chemotherapy             
Other gloves (e.g. vinyl)             
Double gloves             
Gowns labeled for use with chemotherapy             
Other gowns (e.g. isolation)             
Do you re-use disposable gowns?             
Eye protection             
Respirator/mask             
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Section 6 Chemotherapy Disposal: 
Are you responsible for disposing of chemotherapy? 
  Yes    No → If you answered “No” proceed to Section 7. 
Complete this section ONLY if you dispose of chemotherapy.  
Please indicate how much of the time you use the following when disposing of chemotherapy: 
 Always 76-99% 51-75% 26-50% 1-25% Never 
Gloves labeled for use with chemotherapy             
Other gloves (e.g. vinyl)             
Double gloves             
Gowns labeled for use with chemotherapy             
Other gowns (e.g. isolation)             
Do you re-use disposable gowns?             
Eye protection             
Respirator/mask             
 
Section 7 Handling Contaminated Excreta: 
Are you responsible for handling chemotherapy-contaminated excreta? 
  Yes    No → If you answered “No” proceed to Section 8. 
Complete this section ONLY if you handle chemotherapy-contaminated excreta.  
Please indicate how much of the time you use the following when handling excreta:  
 Always 76-99% 51-75% 26-50% 1-25% Never 
Gloves labeled for use with chemotherapy             
Other gloves (e.g. vinyl)             
Double gloves             
Gowns labeled for use with chemotherapy             
Other gowns (e.g. isolation)             
Do you re-use disposable gowns?             
Eye protection             
Respirator/mask             
 
Section 8 
Are chemotherapy spill kits available in your work area?   Yes   No 
During the most recent chemotherapy spill in your workplace, 
did you use the materials in the spill kit?   Yes   No   N/A 
Please write the name of three chemotherapy drugs that you handle most frequently: 
___________________________________________ 
___________________________________________ 
___________________________________________ 
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Section 9 
 
Indicate your level of agreement with each of the following statements. 
SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree: 
Some reasons that I may not wear PPE regularly when 
handling chemotherapy are: 
SA A D SD
1. I don’t think PPE is necessary          
2. I don’t think PPE works          
3. I don’t have the time to use PPE         
4. I was not trained to use PPE          
5. PPE is uncomfortable to wear          
6. PPE makes it harder to get the job done          
7. PPE is not always available          
8. Others around me don’t use PPE          
9. There is no policy requiring PPE          
10. People would think I am overly cautious          
11. It is hard to get chemotherapy-designated PPE          
12. PPE is too expensive to use it all the time          
13. PPE makes me feel too hot          
 
Section 10 
Indicate your level of agreement with each of the following statements about the risks of 
chemotherapy exposure. 
SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree: 
 SA A D SD
1. Exposure to chemotherapy is a serious problem at work         
2. I am concerned about chemotherapy exposure at work and how it 
might affect my health 
        
3. Compared to co-workers, my chance of harm from chemotherapy 
exposure is lower 
        
4. If exposed to chemotherapy, there is a real chance that I might 
experience bad effects 
        
5. Chemotherapy exposure is not as harmful as some people claim         
6. Compared to other work-related health risks, chemotherapy exposure 
is less serious 
        
7. I am not worried about future negative health effects from 
chemotherapy exposure 
        
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Section 11 
How often do the following people wear personal protective equipment when handling 
chemotherapy? 
 Never Sometimes About Half Usually 
Does not 
apply 
Your co-workers           
Other nurses you know           
Oncology nurses in general           
According to the following people, how important is wearing PPE when handling 
chemotherapy?  
 Not at all 
important 
Sort Of 
important
Very 
important 
Does not 
apply 
Your co-workers         
Other nurses you know         
Your supervisor or manager         
Your employer         
 
Section 12 
 
Indicate your level of agreement with each of the following statements. 
 
SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree: 
 SA A D SD
1. Personal protective equipment keeps me from doing my job to the 
best of my abilities.         
2. Wearing personal protective equipment makes my patients worry.         
3. Patient care often interferes with my being able to comply with using 
precautions.         
4. I cannot always use safe handling precautions because patient’s 
needs come first.         
5. Sometimes I have to choose between wearing PPE and caring for my 
patients         
6. Wearing personal protective equipment makes my patients feel 
uncomfortable.         
 
  
128 
 
 
 
Section 13 
Indicate your level of agreement with these statements regarding safety in your work place: 
SA = Strongly Agree; A = Agree; N = Neutral; D = Disagree; SD = Strongly Disagree: 
 
 SA A N D SD
1. Chemotherapy gloves are readily accessible in my work area           
2. Chemotherapy gowns are readily available in my work area           
3. The protection of workers from occupational exposure to 
chemotherapy is a high priority with management where I work 
          
4. On my unit, all reasonable steps are taken to minimize hazardous 
job tasks 
          
5. Employees are encouraged to become involved in safety and 
health matters 
          
6. Managers on my unit do their part to insure employees’ 
protection from occupational exposure to chemotherapy 
          
7. My job duties do not often interfere with my being able to 
follow chemotherapy safe handling precautions 
          
8. I have enough time in my work to always follow chemotherapy 
safe handling precautions 
          
9. I usually do not have too much to do so that I can follow 
chemotherapy safe handling precautions 
          
10. On my unit, unsafe work practices are corrected by supervisors           
11. My supervisor talks to me about safe work practices           
12. I have had the opportunity to be properly trained to use personal 
protective equipment so that I can protect myself from 
chemotherapy exposures 
          
13. Employees are taught to be aware of and to recognize potential 
health hazards at work 
          
14. In my work area, I have access to policies and procedures 
regarding safety 
          
15. My work area is kept clean           
16. My work area is not cluttered           
17. My work area is not crowded           
18. There is minimal conflict within my work area           
19. The members of my work area support one another           
20. In my work area, there is open communication between 
supervisors and staff 
          
21. In my work area we are expected to comply with safe handling 
policies and procedures 
          
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Section 14 
 
In what type of setting you do handle chemotherapy? 
  Inpatient   Outpatient   Both 
Please indicate the type of facility you work in: 
  Academic health center   Private physician office 
  Community non-teaching hospital   Public/Government hospital 
  Community teaching hospital   Home care 
  Health Maintenance organization   Other _________________________ 
Please indicate the primary state in which you work: ____________________ 
 
What is your gender?    Male   Female 
 
What is your RACE or ETHNIC IDENTITY? 
  American Indian/Alaskan Native   Hispanic/ Latino   Two or more 
  Asian   Native Hawaiian   Other 
  Black/African American   White  
What is your highest level of NURSING education? 
  Diploma   Bachelor’s degree   Doctoral Degree 
  Associate degree   Masters degree  
Are you a member of the Oncology Nursing Society? 
  Yes    No 
Are you certified in nursing? 
  Not certified   AOCN®   NP   Other _______________ 
  OCN®   AOCNS®   AOCNP®  
Please enter the number requested: 
Your age in years:    
Years of nursing experience:    
Years of oncology nursing experience:    
Years of chemotherapy handling experience:    
Number of patients for whom you personally 
prepare and/or administer chemotherapy per day   
 
Number of patients receiving chemotherapy per 
day at your work place:   
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Nurses’ Use of Chemotherapy Safe Handling Precautions 
Interview Guide for Managers 
Introduce yourself as follows: 
My name is __________. I am a research assistant at Georgia State University. I am 
calling you for an interview about nurses’ who handle chemotherapy in your 
workplace. 
Did you receive the consent form? (If no, ask for a fax number so that you can send a 
copy of the consent form and reschedule the interview.) 
Do you have any questions about the information in the consent form?  
START RECORDING. DO NOT USE THE PARTICIPANT’S NAME DURING THE 
RECORDING. 
Do you agree to be interviewed for this study? This interview will be audio recorded. Do 
you agree to have the interview recorded? By answering questions in this 
telephone interview you are indicating your consent to participate in this research. 
You need not return the consent form to us; the consent form is for your records.  
 
1. Do you manage or supervise nurses who handle chemotherapy, including 
preparation, administration, disposal or handling of contaminated excreta?  
If answer is no, say: We want to interview people who manage or supervise 
nurses who handle chemotherapy. Thank you for your interest in this research. 
(End the interview.) 
If answer is yes, continue with question 2. 
 
2. What is your title? (The official title for the position you hold at work—manager, 
supervisor, director. Write this down reference later.)  
_________________________________________________________________ 
3. Have you personally handled chemotherapy, including preparation, 
administration, disposal or handling contaminated excreta in the past year?  
(If asked for clarification: By chemotherapy preparation I mean transferring 
chemotherapy drugs from vials or ampoules to syringes or IV container.  
By administration, I mean giving chemotherapy to patients by IV, injection, or other 
route. By handling excreta, I mean activities like emptying bedpans, urinals or 
emesis basins). 
If answer is yes, ask: Is this a regular part of your responsibility as 
(title) _________________________________ 
How frequently do you personally handle chemotherapy? 
(Such as: Daily, weekly, occasionally) 
If answer is no, go on to the next question. 
4. Do the nurses that you supervise prepare or mix chemotherapy? By chemotherapy 
preparation I mean transferring chemotherapy drugs from vials or ampoules to 
syringes or IV container. (If no, ask who prepares chemotherapy in their 
workplace.) 
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5. Do the nurses that you supervise administer chemotherapy? By administration, I 
mean giving chemotherapy to patients by IV, injection, or other route. 
 
6. Do the nurses that you supervise handle contaminated excreta of patients who 
receive chemotherapy? By handling excreta, I mean activities like emptying 
bedpans, urinals or emesis basins. 
 
7. Tell me about the policies regarding safe handling of chemotherapy in your 
workplace. [Such as, are they written or unwritten? Who wrote them? Who was 
involved in decisions about safe handling policies? Are the policies the same for 
everyone in the workplace such as pharmacy, if applicable? Are the policies 
readily available to the nurses? What aspects of chemotherapy handling are 
addressed in the policies? (Ask about these if they do not mention them). Does 
your policy specifically address: 
who may give chemotherapy  
what personal protective equipment is required when handling chemotherapy  
disposal 
transporting chemotherapy 
spill cleanup  
exposure management  
health monitoring of employees 
 
8. How do you ensure that the policies regarding safe handling of chemotherapy are 
complied with? (Such as planned, formal evaluation of practice? Informal “spot 
checks.”Ask for a description). 
 
9. How often are policies regarding safe handling reviewed and updated?  
 
10. Tell me about the training and orientation that a new nurse receives in your 
workplace before handling chemotherapy. (Formal, informal; who conducts; how 
long is it. Does it include safe handling precautions?) 
 
11. How do you evaluate nurses’ knowledge and performance of safe handling 
precautions? (formal, informal; who conducts and how; how often?) 
 
12. I want you to answer the following questions about your workplace the way that 
you think the nurses you supervise would answer them.  
 
(Verbal administration of the Safety Climate Questionnaire follows.) 
 
13. If nurses do not wear gloves or gowns when preparing or administering 
chemotherapy, why do you think that is? (If they do not, have you ever asked the 
nurses why? 
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14. Do you think that chemotherapy exposure is a problem in your work site? (Why 
or why not?) 
 
15. The following questions are about your work site. What kind of organization do 
you work in? 
 
  Inpatient 
  Outpatient 
  Both 
Academic health center   
Community non-teaching hospital   
Community teaching hospital   
Health maintenance organization  
Private physician office   
Public/ Government hospital   
Home Care   
Other (please describe)   
 
16. Please indicate the primary state in which you work:   
17. Your Gender    Female   Male 
18. Are you a nurse?   Yes    No 
19. Your age in years:   
20. Number of years in your current position:   
21. Number of years of nursing experience:   
22. How many employees do you supervise?   
23. Number of patients treated /day at your worksite   
24. Is there anything else you would like to tell me about safe handling precautions in your 
workplace?  
 
Thank you very much for participating in this study. When we contacted you originally, 
we sent you one questionnaire for a nurse in your workplace to complete. Are you willing 
to give a questionnaire to another nurse in your workplace who handles chemotherapy? 
 
If NO—Thank you. [End recording]. We really appreciate your willingness to participate 
in this study. The information you have shared with us will help us understand managers’ 
perspectives on the use of chemotherapy safe handling precautions. We will use the 
results to help improve safety for oncology nurses. [End interview]. 
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IF YES:  Thank you. We will send another nurse questionnaire to you at the same 
address we used to contact you for the study. Is that OK?  [End recording] (Or, please tell 
us where to send the questionnaire and write down the address). [Do not audio-record the 
address]. 
 
We really appreciate your willingness to participate in this study. The information you 
have shared with us will help us understand managers’ perspectives on the use of 
chemotherapy safe handling precautions. We will use the results to help improve safety 
for oncology nurses. [End interview]. 
 
 
